[P02BB01, trichlorfon, The therapeutic efficacy of Quinidine can be decreased when used in combination with Metrifonate.]
[S02DA03, antipyrine, The metabolism of Antipyrine can be decreased when combined with Quinidine.]
[B01AD01, streptokinase, The therapeutic efficacy of Streptokinase can be increased when used in combination with Quinidine.]
[J01GA01, streptomycin, Streptomycin may decrease the excretion rate of Quinidine which could result in a higher serum level.]
[L04AA27, fingolimod, Fingolimod may increase the arrhythmogenic activities of Quinidine.]
[M03AB01, succinylcholine, The therapeutic efficacy of Succinylcholine can be increased when used in combination with Quinidine.]
[A02BX02, sucralfate, Sucralfate can cause a decrease in the absorption of Quinidine resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[J01CG01, sulbactam, Sulbactam may decrease the excretion rate of Quinidine which could result in a higher serum level.]
[J01EC02, sulfadiazine, Sulfadiazine may decrease the excretion rate of Quinidine which could result in a higher serum level.]
[J01EC01, sulfamethoxazole, The metabolism of Quinidine can be decreased when combined with Sulfamethoxazole.]
[M04AB02, sulfinpyrazone, The metabolism of Quinidine can be increased when combined with Sulfinpyrazone.]
[S01AB02, sulfisoxazole, The risk or severity of QTc prolongation can be increased when Sulfisoxazole is combined with Quinidine.]
[M01AB02, sulindac, Sulindac may decrease the excretion rate of Quinidine which could result in a higher serum level.]
[N05AL01, sulpiride, Quinidine may increase the anticholinergic activities of Sulpiride.]
[N03AX03, sulthiame, Sulthiame may increase the central nervous system depressant (CNS depressant) activities of Quinidine.]
[A10BB04, glibornuride, The metabolism of Glibornuride can be decreased when combined with Quinidine.]
[M01AX04, apazone, Azapropazone may decrease the excretion rate of Quinidine which could result in a higher serum level.]
[L01BB02, mercaptopurine, The serum concentration of Mercaptopurine can be increased when it is combined with Quinidine.]
[N06DA01, tacrine, The metabolism of Tacrine can be decreased when combined with Quinidine.]
[L02BA01, tamoxifen, The serum concentration of Quinidine can be increased when it is combined with Tamoxifen.]
[N05CD07, temazepam, Temazepam may decrease the excretion rate of Quinidine which could result in a higher serum level.]
[L01CB02, teniposide, The metabolism of Teniposide can be decreased when combined with Quinidine.]
[R03CC03, terbutaline, Terbutaline may decrease the excretion rate of Quinidine which could result in a higher serum level.]
[B01AE07, dabigatran etexilate, The serum concentration of Dabigatran etexilate can be increased when it is combined with Quinidine.]
[G03BA03, testosterone, The metabolism of Quinidine can be increased when combined with Testosterone.]
[N07XX06, tetrabenazine, The metabolism of Tetrabenazine can be decreased when combined with Quinidine.]
[S01HA03, tetracaine, The risk or severity of methemoglobinemia can be increased when Quinidine is combined with Tetracaine.]
[S03AA02, tetracycline, The serum concentration of Quinidine can be increased when it is combined with Tetracycline.]
[J01DI02, ceftaroline fosamil, Ceftaroline fosamil may decrease the excretion rate of Quinidine which could result in a higher serum level.]
[N05AE05, lurasidone, Quinidine may increase the hypotensive activities of Lurasidone.]
[A04AD10, dronabinol, The serum concentration of Dronabinol can be increased when it is combined with Quinidine.]
[N04BC07, apomorphine, Apomorphine may increase the central nervous system depressant (CNS depressant) activities of Quinidine.]
[L04AX02, thalidomide, Thalidomide may increase the central nervous system depressant (CNS depressant) activities of Quinidine.]
[R03DA07, theobromine, The serum concentration of Theobromine can be increased when it is combined with Quinidine.]
[R03DA04, theophylline, The serum concentration of Theophylline can be increased when it is combined with Quinidine.]
[P02CA02, thiabendazole, The metabolism of Thiabendazole can be decreased when combined with Quinidine.]
[A11DA01, thiamine, The risk or severity of adverse effects can be increased when Quinidine is combined with Thiamine.]
[L01XX41, eribulin, The risk or severity of QTc prolongation can be increased when Eribulin is combined with Quinidine.]
[R06AD03, thiethylperazine, The risk or severity of QTc prolongation can be increased when Quinidine is combined with Thiethylperazine.]
[L01AC01, thiotepa, The metabolism of Thiotepa can be decreased when combined with Quinidine.]
[N05CA19, thiopental, Thiopental may increase the central nervous system depressant (CNS depressant) activities of Quinidine.]
[N05AB08, thioproperazine, Quinidine may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Thioproperazine.]
[N05AC02, thioridazine, Thioridazine may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Quinidine.]
[N05AF04, thiothixene, The metabolism of Thiothixene can be decreased when combined with Quinidine.]
[C01BB04, aprindine, Quinidine may increase the arrhythmogenic activities of Aprindine.]
[B02AB01, aprotinin, The therapeutic efficacy of Quinidine can be decreased when used in combination with Aprotinin.]
[G04BE06, moxisylyte, Moxisylyte may decrease the excretion rate of Quinidine which could result in a higher serum level.]
[N05AL03, tiapride, Tiapride may decrease the excretion rate of Quinidine which could result in a higher serum level.]
[B01AC05, ticlopidine, The metabolism of Ticlopidine can be decreased when combined with Quinidine.]
[N02AX01, tilidine, The risk or severity of adverse effects can be increased when Quinidine is combined with Tilidine.]
[S01ED01, timolol, The risk or severity of bradycardia can be increased when Quinidine is combined with Timolol.]
[P01AB02, tinidazole, Tinidazole may decrease the excretion rate of Quinidine which could result in a higher serum level.]
[S01AA12, tobramycin, Tobramycin may decrease the excretion rate of Quinidine which could result in a higher serum level.]
[A10BB05, tolazamide, Tolazamide may decrease the excretion rate of Quinidine which could result in a higher serum level.]
[M02AX02, tolazoline, Tolazoline may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Quinidine.]
[V04CA01, tolbutamide, Tolbutamide may decrease the excretion rate of Quinidine which could result in a higher serum level.]
[M02AA21, tolmetin, Tolmetin may decrease the excretion rate of Quinidine which could result in a higher serum level.]
[M03BX04, tolperisone, Tolperisone may increase the central nervous system depressant (CNS depressant) activities of Quinidine.]
[N02AX02, tramadol, The metabolism of Tramadol can be decreased when combined with Quinidine.]
[N06AF04, tranylcypromine, Tranylcypromine may increase the central nervous system depressant (CNS depressant) activities of Quinidine.]
[N06AX05, trazodone, The risk or severity of QTc prolongation can be increased when Trazodone is combined with Quinidine.]
[L01XF01, tretinoin, The metabolism of Quinidine can be decreased when combined with Tretinoin.]
[S01BA05, triamcinolone, The metabolism of Quinidine can be increased when combined with Triamcinolone.]
[C03DB02, triamterene, The metabolism of Triamterene can be decreased when combined with Quinidine.]
[N05CD05, triazolam, The metabolism of Quinidine can be decreased when combined with Triazolam.]
[C03AA06, trichlormethiazide, Trichlormethiazide may increase the excretion rate of Quinidine which could result in a lower serum level and potentially a reduction in efficacy.]
[A03AB12, mepenzolate, The risk or severity of adverse effects can be increased when Quinidine is combined with Mepenzolate.]
[S01EB04, demecarium, The therapeutic efficacy of Quinidine can be decreased when used in combination with Demecarium.]
[A16AX12, trientine, Triethylenetetramine may decrease the excretion rate of Quinidine which could result in a higher serum level.]
[N05AB06, trifluoperazine, Trifluoperazine may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Quinidine.]
[S01AD02, trifluridine, Trifluridine may decrease the excretion rate of Quinidine which could result in a higher serum level.]
[N05AD02, trifluperidol, Trifluperidol may increase the central nervous system depressant (CNS depressant) activities of Quinidine.]
[N05AA05, triflupromazine, The risk or severity of QTc prolongation can be increased when Quinidine is combined with Triflupromazine.]
[N04AA01, trihexyphenidyl, The risk or severity of adverse effects can be increased when Trihexyphenidyl is combined with Quinidine.]
[R03BA07, mometasone, The metabolism of Quinidine can be increased when combined with Mometasone.]
[A03AA05, trimebutine, Quinidine may increase the arrhythmogenic activities of Trimebutine.]
[S01ED04, metipranolol, Quinidine may increase the arrhythmogenic activities of Metipranolol.]
[R06AD01, trimeprazine, The risk or severity of QTc prolongation can be increased when Quinidine is combined with Alimemazine.]
[N03AC02, trimethadione, Trimethadione may increase the arrhythmogenic activities of Quinidine.]
[C02BA01, trimethaphan, The risk or severity of adverse effects can be increased when Quinidine is combined with Trimethaphan.]
[J01EA01, trimethoprim, Trimethoprim may decrease the excretion rate of Quinidine which could result in a higher serum level.]
[N06AA06, trimipramine, Trimipramine may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Quinidine.]
[R06AX07, triprolidine, Triprolidine may increase the central nervous system depressant (CNS depressant) activities of Quinidine.]
[A03BB01, butylscopolamine, The risk or severity of adverse effects can be increased when Quinidine is combined with Butylscopolamine.]
[J01FA08, troleandomycin, The metabolism of Quinidine can be decreased when combined with Troleandomycin.]
[N06AX24, vilazodone, The metabolism of Vilazodone can be decreased when combined with Quinidine.]
[S01FA06, tropicamide, The risk or severity of adverse effects can be increased when Tropicamide is combined with Quinidine.]
[N06AX02, tryptophan, Tryptophan may increase the central nervous system depressant (CNS depressant) activities of Quinidine.]
[C09CA09, azilsartan medoxomil, Quinidine may decrease the antihypertensive activities of Azilsartan medoxomil.]
[M03AA02, tubocurarine, The therapeutic efficacy of Tubocurarine can be increased when used in combination with Quinidine.]
[R03DX07, roflumilast, The serum concentration of Roflumilast can be increased when it is combined with Quinidine.]
[L01FX04, ipilimumab, Ipilimumab may decrease the excretion rate of Quinidine which could result in a higher serum level.]
[S01AA05, tyrothricin, The therapeutic efficacy of Quinidine can be decreased when used in combination with Tyrothricin.]
[L01EX04, vandetanib, The serum concentration of Quinidine can be increased when it is combined with Vandetanib.]
[R02AA14, oxyquinoline, Oxyquinoline may decrease the excretion rate of Quinidine which could result in a higher serum level.]
[A10BH05, linagliptin, The serum concentration of Quinidine can be increased when it is combined with Linagliptin.]
[J05AP03, boceprevir, The metabolism of Quinidine can be decreased when combined with Boceprevir.]
[J05AP02, telaprevir, The metabolism of Quinidine can be decreased when combined with Telaprevir.]
[J05AG05, rilpivirine, The serum concentration of Rilpivirine can be increased when it is combined with Quinidine.]
[B01AD04, urokinase, The therapeutic efficacy of Urokinase can be increased when used in combination with Quinidine.]
[S01AA28, vancomycin, Vancomycin may decrease the excretion rate of Quinidine which could result in a higher serum level.]
[N03AX21, ezogabine, Ezogabine may decrease the excretion rate of Quinidine which could result in a higher serum level.]
[B01AF01, rivaroxaban, The therapeutic efficacy of Rivaroxaban can be increased when used in combination with Quinidine.]
[R03AC18, indacaterol, The therapeutic efficacy of Indacaterol can be decreased when used in combination with Quinidine.]
[B01AC24, ticagrelor, The therapeutic efficacy of Ticagrelor can be increased when used in combination with Quinidine.]
[C08DA01, verapamil, Verapamil may increase the hypotensive activities of Quinidine.]
[N06AX09, viloxazine, The metabolism of Quinidine can be decreased when combined with Viloxazine.]
[L01CA01, vinblastine, The serum concentration of Vinblastine can be increased when it is combined with Quinidine.]
[C04AX07, vincamine, Quinidine may decrease the antihypertensive activities of Vincamine.]
[L01CA02, vincristine, The excretion of Vincristine can be decreased when combined with Quinidine.]
[L01CA03, vindesine, The metabolism of Vindesine can be decreased when combined with Quinidine.]
[B03BA01, vitamin B12, Cyanocobalamin may decrease the excretion rate of Quinidine which could result in a higher serum level.]
[A11HA03, vitamin E, The metabolism of Quinidine can be increased when combined with Vitamin E.]
[B01AA03, warfarin, The serum concentration of Warfarin can be increased when it is combined with Quinidine.]
[S01AA13, fusidic acid, The metabolism of Quinidine can be decreased when combined with Fusidic acid.]
[N01AX15, xenon, The risk or severity of hypertension can be increased when Quinidine is combined with Xenon.]
[C03BA10, xipamide, Xipamide may increase the excretion rate of Quinidine which could result in a lower serum level and potentially a reduction in efficacy.]
[J01MB04, pipemidic acid, The risk or severity of QTc prolongation can be increased when Pipemidic acid is combined with Quinidine.]
[J05AF01, zidovudine, The excretion of Zidovudine can be decreased when combined with Quinidine.]
[N05AF05, zuclopenthixol, Quinidine may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Zuclopenthixol.]
[J05AE02, indinavir, The metabolism of Quinidine can be decreased when combined with Indinavir.]
[N03AX14, levetiracetam, Levetiracetam may increase the central nervous system depressant (CNS depressant) activities of Quinidine.]
[L01EC01, vemurafenib, The risk or severity of QTc prolongation can be increased when Vemurafenib is combined with Quinidine.]
[M05BA03, pamidronic acid, Pamidronic acid may decrease the excretion rate of Quinidine which could result in a higher serum level.]
[L01FX05, brentuximab vedotin, The serum concentration of Brentuximab vedotin can be increased when it is combined with Quinidine.]
[M05BA05, tiludronic acid, Tiludronic acid may decrease the excretion rate of Quinidine which could result in a higher serum level.]
[B06AC02, icatibant, Icatibant may decrease the excretion rate of Quinidine which could result in a higher serum level.]
[L01ED01, crizotinib, The metabolism of Quinidine can be decreased when combined with Crizotinib.]
[B01AE01, desirudin, The therapeutic efficacy of Lepirudin can be increased when used in combination with Quinidine.]
[R03DC01, zafirlukast, The metabolism of Quinidine can be decreased when combined with Zafirlukast.]
[A02BC04, rabeprazole, Rabeprazole may decrease the excretion rate of Quinidine which could result in a higher serum level.]
[M05BA06, ibandronic acid, The risk or severity of QTc prolongation can be increased when Ibandronate is combined with Quinidine.]
[J01MA13, trovafloxacin, The risk or severity of QTc prolongation can be increased when Trovafloxacin is combined with Quinidine.]
[N05AE04, ziprasidone, The risk or severity of QTc prolongation can be increased when Quinidine is combined with Ziprasidone.]
[G03AC10, drospirenone, The metabolism of Quinidine can be decreased when combined with Drospirenone.]
[V03AC02, deferiprone, Deferiprone may decrease the excretion rate of Quinidine which could result in a higher serum level.]
[N02BA01, aspirin, Acetylsalicylic acid may decrease the excretion rate of Quinidine which could result in a higher serum level.]
[L01EJ01, ruxolitinib, The metabolism of Ruxolitinib can be decreased when combined with Quinidine.]
[G04BD07, tolterodine, The metabolism of Tolterodine can be decreased when combined with Quinidine.]
[J01DH04, doripenem, Doripenem may decrease the excretion rate of Quinidine which could result in a higher serum level.]
[C07AB03, atenolol, Atenolol may increase the arrhythmogenic activities of Quinidine.]
[J02AC03, voriconazole, The risk or severity of QTc prolongation and torsade de pointes can be increased when Voriconazole is combined with Quinidine.]
[M03AC04, atracurium, The therapeutic efficacy of Atracurium can be increased when used in combination with Quinidine.]
[S01FA01, atropine, Atropine may increase the arrhythmogenic activities of Quinidine.]
[M01CB03, auranofin, Auranofin may decrease the excretion rate of Quinidine which could result in a higher serum level.]
[L01XJ01, vismodegib, The metabolism of Vismodegib can be decreased when combined with Quinidine.]
[L01EK01, axitinib, The serum concentration of Axitinib can be increased when it is combined with Quinidine.]
[R07AX02, ivacaftor, The serum concentration of Quinidine can be increased when it is combined with Ivacaftor.]
[H02AB11, prednylidene, The metabolism of Quinidine can be increased when combined with Prednylidene.]
[B03XA04, peginesatide, Peginesatide may decrease the excretion rate of Quinidine which could result in a higher serum level.]
[L01BC07, azacitidine, Azacitidine may decrease the excretion rate of Quinidine which could result in a higher serum level.]
[L04AX01, azathioprine, The metabolism of Azathioprine can be decreased when combined with Quinidine.]
[L01BC05, gemcitabine, The serum concentration of Gemcitabine can be increased when it is combined with Quinidine.]
[J01DF01, aztreonam, Aztreonam may decrease the excretion rate of Quinidine which could result in a higher serum level.]
[R02AB04, bacitracin, Bacitracin may decrease the excretion rate of Quinidine which could result in a higher serum level.]
[G04BE10, avanafil, Quinidine may increase the hypotensive activities of Avanafil.]
[M03BX01, baclofen, Baclofen may decrease the excretion rate of Quinidine which could result in a higher serum level.]
[A08AA11, lorcaserin, The metabolism of Lorcaserin can be decreased when combined with Quinidine.]
[G04BD12, mirabegron, The risk or severity of urinary retention can be increased when Quinidine is combined with Mirabegron.]
[L01XG02, carfilzomib, The serum concentration of Carfilzomib can be increased when it is combined with Quinidine.]
[V03AX03, cobicistat, The metabolism of Quinidine can be decreased when combined with Cobicistat.]
[J05AJ02, elvitegravir, The metabolism of Quinidine can be decreased when combined with Elvitegravir.]
[L02BB04, enzalutamide, The serum concentration of Quinidine can be decreased when it is combined with Enzalutamide.]
[A06AX04, linaclotide, The therapeutic efficacy of Linaclotide can be decreased when used in combination with Quinidine.]
[L01EA04, bosutinib, The serum concentration of Bosutinib can be increased when it is combined with Quinidine.]
[A02AA05, magnesium silicate, Magnesium silicate may decrease the excretion rate of Quinidine which could result in a higher serum level.]
[B01AX01, defibrotide, The therapeutic efficacy of Defibrotide can be increased when used in combination with Quinidine.]
[C01CA18, octopamine, The therapeutic efficacy of Octopamine can be decreased when used in combination with Quinidine.]
[A02AC02, calcium silicate, Calcium silicate may decrease the excretion rate of Quinidine which could result in a higher serum level.]
[L01EX05, regorafenib, The serum concentration of Regorafenib can be increased when it is combined with Quinidine.]
[N05CA04, barbital, The metabolism of Quinidine can be increased when combined with Barbital.]
[C01AA01, acetyldigitoxin, The serum concentration of Acetyldigitoxin can be increased when it is combined with Quinidine.]
[D02BA02, octinoxate, Octinoxate may decrease the excretion rate of Quinidine which could result in a higher serum level.]
[J05AE04, nelfinavir, The metabolism of Quinidine can be decreased when combined with Nelfinavir.]
[L01AA09, bendamustine, The serum concentration of Bendamustine can be increased when it is combined with Quinidine.]
[N04BD02, rasagiline, The serum concentration of Rasagiline can be increased when it is combined with Quinidine.]
[C08CA13, lercanidipine, Lercanidipine may increase the arrhythmogenic activities of Quinidine.]
[A03FA09, mosapride, Mosapride may increase the central nervous system depressant (CNS depressant) activities of Quinidine.]
[N06DA02, donepezil, The therapeutic efficacy of Quinidine can be decreased when used in combination with Donepezil.]
[N03AX22, perampanel, The metabolism of Quinidine can be increased when combined with Perampanel.]
[L04AA29, tofacitinib, The metabolism of Tofacitinib can be decreased when combined with Quinidine.]
[N02CC03, zolmitriptan, The metabolism of Zolmitriptan can be decreased when combined with Quinidine.]
[R06AC06, thonzylamine, The risk or severity of adverse effects can be increased when Quinidine is combined with Thonzylamine.]
[G04BD10, darifenacin, The metabolism of Darifenacin can be decreased when combined with Quinidine.]
[V09IX04, fluorodeoxyglucose F18, Fludeoxyglucose (18F) may decrease the excretion rate of Quinidine which could result in a higher serum level.]
[N01AA01, ethyl ether, Diethyl ether may increase the central nervous system depressant (CNS depressant) activities of Quinidine.]
[L01EX07, cabozantinib, The metabolism of Cabozantinib can be decreased when combined with Quinidine.]
[H01CB05, pasireotide, The metabolism of Quinidine can be decreased when combined with Pasireotide.]
[G04BE03, sildenafil, The serum concentration of Quinidine can be increased when it is combined with Sildenafil.]
[V08CA11, gadofosveset, Gadofosveset trisodium may decrease the excretion rate of Quinidine which could result in a higher serum level.]
[L01EA05, ponatinib, The serum concentration of Quinidine can be increased when it is combined with Ponatinib.]
[B01AF02, apixaban, The therapeutic efficacy of Apixaban can be increased when used in combination with Quinidine.]
[A16AX08, teduglutide, Teduglutide may decrease the excretion rate of Quinidine which could result in a higher serum level.]
[C10AX12, lomitapide, The metabolism of Lomitapide can be decreased when combined with Quinidine.]
[J04AK05, bedaquiline, The risk or severity of QTc prolongation can be increased when Bedaquiline is combined with Quinidine.]
[C04AX11, bencyclane, Quinidine may increase the arrhythmogenic activities of Bencyclane.]
[A10BH04, alogliptin, The metabolism of Alogliptin can be decreased when combined with Quinidine.]
[A16AX09, glycerol phenylbutyrate, The metabolism of Quinidine can be increased when combined with Glycerol phenylbutyrate.]
[C03AA01, bendroflumethiazide, Bendroflumethiazide may increase the excretion rate of Quinidine which could result in a lower serum level and potentially a reduction in efficacy.]
[L04AX06, pomalidomide, The serum concentration of Pomalidomide can be increased when it is combined with Quinidine.]
[G03XC05, ospemifene, The metabolism of Ospemifene can be decreased when combined with Quinidine.]
[N02BA10, benorilate, Benorilate may decrease the excretion rate of Quinidine which could result in a higher serum level.]
[N05AD07, benperidol, Benperidol may increase the central nervous system depressant (CNS depressant) activities of Quinidine.]
[A10BK02, canagliflozin, The serum concentration of Quinidine can be increased when it is combined with Canagliflozin.]
[J01MA15, gemifloxacin, The risk or severity of QTc prolongation can be increased when Gemifloxacin is combined with Quinidine.]
[M04AB03, benzbromarone, Quinidine may decrease the excretion rate of Benzbromarone which could result in a higher serum level.]
[A12CC09, magnesium orotate, The risk or severity of neuromuscular blockade can be increased when Quinidine is combined with Magnesium orotate.]
[S01AE07, moxifloxacin, The risk or severity of QTc prolongation can be increased when Moxifloxacin is combined with Quinidine.]
[A06AX06, tegaserod, The metabolism of Tegaserod can be decreased when combined with Quinidine.]
[R02AD01, benzocaine, The risk or severity of methemoglobinemia can be increased when Quinidine is combined with Benzocaine.]
[A10BX05, pramlintide, The risk or severity of reduced gastrointestinal motility can be increased when Pramlintide is combined with Quinidine.]
[J02AX04, caspofungin, The excretion of Caspofungin can be decreased when combined with Quinidine.]
[L03AA12, ancestim, Ancestim may decrease the excretion rate of Quinidine which could result in a higher serum level.]
[M01AH01, celecoxib, The metabolism of Celecoxib can be decreased when combined with Quinidine.]
[N02CC02, naratriptan, Naratriptan may increase the central nervous system depressant (CNS depressant) activities of Quinidine.]
[L04AA18, everolimus, The serum concentration of Everolimus can be increased when it is combined with Quinidine.]
[A12CC05, magnesium aspartate, The risk or severity of neuromuscular blockade can be increased when Quinidine is combined with Magnesium aspartate.]
[N04AC01, benztropine, The metabolism of Benzatropine can be decreased when combined with Quinidine.]
[L01EC02, dabrafenib, The serum concentration of Quinidine can be decreased when it is combined with Dabrafenib.]
[R02AX03, benzydamine, Benzydamine may decrease the excretion rate of Quinidine which could result in a higher serum level.]
[L01EE01, trametinib, Trametinib may decrease the excretion rate of Quinidine which could result in a higher serum level.]
[P03AX06, benzyl alcohol, The risk or severity of methemoglobinemia can be increased when Quinidine is combined with Benzyl alcohol.]
[V09AX05, florbetapir F-18, Florbetapir (18F) may decrease the excretion rate of Quinidine which could result in a higher serum level.]
[L01EB03, afatinib, The serum concentration of Afatinib can be increased when it is combined with Quinidine.]
[N06AX28, levomilnacipran, The metabolism of Levomilnacipran can be decreased when combined with Quinidine.]
[J05AJ03, dolutegravir, The serum concentration of Dolutegravir can be increased when it is combined with Quinidine.]
[C08EA02, bepridil, Quinidine may increase the arrhythmogenic activities of Bepridil.]
[C02KX05, riociguat, The serum concentration of Riociguat can be increased when it is combined with Quinidine.]
[A10BJ03, lixisenatide, Lixisenatide may decrease the excretion rate of Quinidine which could result in a higher serum level.]
[A05AA03, cholic acid, Quinidine may decrease the excretion rate of Cholic Acid which could result in a higher serum level.]
[C02KX04, macitentan, Macitentan may decrease the excretion rate of Quinidine which could result in a higher serum level.]
[L01EL01, ibrutinib, The metabolism of Ibrutinib can be decreased when combined with Quinidine.]
[N06AX26, vortioxetine, The metabolism of Vortioxetine can be decreased when combined with Quinidine.]
[G03AC08, etonogestrel, Etonogestrel may decrease the excretion rate of Quinidine which could result in a higher serum level.]
[N03AF04, eslicarbazepine, The metabolism of Quinidine can be increased when combined with Eslicarbazepine.]
[J05AP05, simeprevir, The serum concentration of Quinidine can be increased when it is combined with Simeprevir.]
[J05AP08, sofosbuvir, Sofosbuvir may decrease the excretion rate of Quinidine which could result in a higher serum level.]
[N03AG04, vigabatrin, Vigabatrin may increase the central nervous system depressant (CNS depressant) activities of Quinidine.]
[A10BK01, dapagliflozin, The metabolism of Dapagliflozin can be decreased when combined with Quinidine.]
[C01CA27, droxidopa, Droxidopa may decrease the excretion rate of Quinidine which could result in a higher serum level.]
[C07AB04, acebutolol, Quinidine may increase the arrhythmogenic activities of Acebutolol.]
[N05CH03, tasimelteon, The serum concentration of Tasimelteon can be increased when it is combined with Quinidine.]
[A16AA07, metreleptin, The metabolism of Quinidine can be increased when combined with Metreleptin.]
[L04AA32, apremilast, The metabolism of Quinidine can be increased when combined with Apremilast.]
[L02BG02, formestane, The metabolism of Quinidine can be increased when combined with Formestane.]
[A16AA06, betaine, The therapeutic efficacy of Quinidine can be decreased when used in combination with Betaine.]
[S03BA03, betamethasone, The metabolism of Quinidine can be increased when combined with Betamethasone.]
[S01ED02, betaxolol, Betaxolol may increase the arrhythmogenic activities of Quinidine.]
[B01AE03, argatroban, The therapeutic efficacy of Argatroban can be increased when used in combination with Quinidine.]
[V03AB34, fomepizole, Fomepizole may decrease the excretion rate of Quinidine which could result in a higher serum level.]
[C02CC01, bethanidine, The therapeutic efficacy of Bethanidine can be decreased when used in combination with Quinidine.]
[L04AC11, siltuximab, The metabolism of Quinidine can be increased when combined with Siltuximab.]
[L01ED02, ceritinib, The serum concentration of Ceritinib can be increased when it is combined with Quinidine.]
[B01AC26, vorapaxar, The therapeutic efficacy of Vorapaxar can be increased when used in combination with Quinidine.]
[A03BA03, hyoscyamine, Hyoscyamine may increase the arrhythmogenic activities of Quinidine.]
[B01AA07, acenocoumarol, The serum concentration of Acenocoumarol can be increased when it is combined with Quinidine.]
[L01XH04, belinostat, The serum concentration of Belinostat can be increased when it is combined with Quinidine.]
[L01EM01, idelalisib, The metabolism of Idelalisib can be decreased when combined with Quinidine.]
[N01AX05, alfaxalone, Alfaxalone may increase the central nervous system depressant (CNS depressant) activities of Quinidine.]
[R03AC19, olodaterol, The therapeutic efficacy of Olodaterol can be decreased when used in combination with Quinidine.]
[V08AA01, diatrizoic acid, Diatrizoate may decrease the excretion rate of Quinidine which could result in a higher serum level.]
[D11AA01, glycopyrronium, The risk or severity of adverse effects can be increased when Quinidine is combined with Glycopyrronium.]
[V08AA04, iothalamic acid, Diatrizoate may decrease the excretion rate of Quinidine which could result in a higher serum level.]
[N05CM19, suvorexant, The serum concentration of Quinidine can be increased when it is combined with Suvorexant.]
[A16AX10, eliglustat, The metabolism of Eliglustat can be decreased when combined with Quinidine.]
[J01XA05, oritavancin, The metabolism of Quinidine can be increased when combined with Oritavancin.]
[S01AA15, dihydrostreptomycin, Dihydrostreptomycin may decrease the excretion rate of Quinidine which could result in a higher serum level.]
[N05AA04, acepromazine, Quinidine may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Acepromazine.]
[V04CX03, methacholine, Quinidine may decrease effectiveness of Methacholine as a diagnostic agent.]
[A06AB04, phenolphthalein, The therapeutic efficacy of Phenolphthalein can be decreased when used in combination with Quinidine.]
[A06AH03, naloxegol, The serum concentration of Naloxegol can be increased when it is combined with Quinidine.]
[N04AA02, biperiden, The risk or severity of adverse effects can be increased when Biperiden is combined with Quinidine.]
[L04AX05, pirfenidone, The metabolism of Pirfenidone can be decreased when combined with Quinidine.]
[L01EX09, nintedanib, The metabolism of Quinidine can be decreased when combined with Nintedanib.]
[A06AG02, bisacodyl, The therapeutic efficacy of Bisacodyl can be decreased when used in combination with Quinidine.]
[S03AA06, gentamicin, The serum concentration of Gentamicin can be increased when it is combined with Quinidine.]
[J05AP09, dasabuvir, The metabolism of Dasabuvir can be decreased when combined with Quinidine.]
[L01XK01, olaparib, The metabolism of Olaparib can be decreased when combined with Quinidine.]
[B01AA01, dicumarol, The therapeutic efficacy of Dicoumarol can be increased when used in combination with Quinidine.]
[B01AF03, edoxaban, The serum concentration of Edoxaban can be increased when it is combined with Quinidine.]
[N06AX11, mirtazapine, The metabolism of Quinidine can be decreased when combined with Mirtazapine.]
[L04AC10, secukinumab, The metabolism of Quinidine can be increased when combined with Secukinumab.]
[L01EF01, palbociclib, The serum concentration of Quinidine can be increased when it is combined with Palbociclib.]
[L01EX08, lenvatinib, The risk or severity of QTc prolongation can be increased when Lenvatinib is combined with Quinidine.]
[L01XH03, panobinostat, The serum concentration of Panobinostat can be increased when it is combined with Quinidine.]
[J05AP07, daclatasvir, The serum concentration of Quinidine can be increased when it is combined with Daclatasvir.]
[N02BE01, acetaminophen, The metabolism of Quinidine can be increased when combined with Acetaminophen.]
[L01DC01, bleomycin, Bleomycin may decrease the excretion rate of Quinidine which could result in a higher serum level.]
[A03AA09, difemerine, The risk or severity of adverse effects can be increased when Quinidine is combined with Difemerine.]
[B01AA11, tioclomarol, The therapeutic efficacy of Tioclomarol can be increased when used in combination with Quinidine.]
[C01EB17, ivabradine, The risk or severity of QTc prolongation can be increased when Quinidine is combined with Ivabradine.]
[J05AF08, adefovir dipivoxil, Adefovir dipivoxil may decrease the excretion rate of Quinidine which could result in a higher serum level.]
[J05AP06, asunaprevir, The serum concentration of Quinidine can be increased when it is combined with Asunaprevir.]
[A07DA06, eluxadoline, The risk or severity of constipation can be increased when Quinidine is combined with Eluxadoline.]
[B01AC25, cangrelor, The therapeutic efficacy of Cangrelor can be increased when used in combination with Quinidine.]
[N05AX16, brexpiprazole, The metabolism of Brexpiprazole can be decreased when combined with Quinidine.]
[L01XJ02, sonidegib, The metabolism of Sonidegib can be decreased when combined with Quinidine.]
[A04AD14, rolapitant, The serum concentration of Quinidine can be increased when it is combined with Rolapitant.]
[G02CX02, flibanserin, The serum concentration of Quinidine can be increased when it is combined with Flibanserin.]
[A06AD03, magnesium peroxide, Magnesium peroxide may decrease the excretion rate of Quinidine which could result in a higher serum level.]
[N05AX15, cariprazine, Cariprazine may increase the central nervous system depressant (CNS depressant) activities of Quinidine.]
[M02AA25, aceclofenac, Aceclofenac may decrease the excretion rate of Quinidine which could result in a higher serum level.]
[M01AB11, acemetacin, Acemetacin may decrease the excretion rate of Quinidine which could result in a higher serum level.]
[S01EC01, acetazolamide, Acetazolamide may decrease the excretion rate of Quinidine which could result in a higher serum level.]
[N05AB07, acetophenazine, The risk or severity of QTc prolongation can be increased when Quinidine is combined with Acetophenazine.]
[A02BC03, lansoprazole, The metabolism of Lansoprazole can be decreased when combined with Quinidine.]
[V03AB37, idarucizumab, Idarucizumab may decrease the excretion rate of Quinidine which could result in a higher serum level.]
[L01CX01, trabectedin, The metabolism of Trabectedin can be decreased when combined with Quinidine.]
[J02AC05, isavuconazole, The serum concentration of Quinidine can be increased when it is combined with Isavuconazole.]
[L01EB04, osimertinib, The serum concentration of Osimertinib can be increased when it is combined with Quinidine.]
[J05AF13, tenofovir alafenamide, The serum concentration of Tenofovir alafenamide can be increased when it is combined with Quinidine.]
[L01EE02, cobimetinib, The serum concentration of Cobimetinib can be increased when it is combined with Quinidine.]
[L01XG03, ixazomib, The metabolism of Ixazomib can be decreased when combined with Quinidine.]
[L01ED03, alectinib, The metabolism of Alectinib can be decreased when combined with Quinidine.]
[B01AC27, selexipag, The serum concentration of Selexipag can be increased when it is combined with Quinidine.]
[A10BB31, acetohexamide, The metabolism of Acetohexamide can be decreased when combined with Quinidine.]
[G04CA01, alfuzosin, Quinidine may increase the hypotensive activities of Alfuzosin.]
[M04AB05, lesinurad, The metabolism of Quinidine can be increased when combined with Lesinurad.]
[J05AP10, elbasvir, The metabolism of Quinidine can be decreased when combined with Elbasvir.]
[J05AP11, grazoprevir, The serum concentration of Grazoprevir can be increased when it is combined with Quinidine.]
[N05CA05, aprobarbital, The metabolism of Quinidine can be increased when combined with Aprobarbital.]
[M01AE16, alminoprofen, Alminoprofen may decrease the excretion rate of Quinidine which could result in a higher serum level.]
[A02AB06, aloglutamol, Aloglutamol may decrease the excretion rate of Quinidine which could result in a higher serum level.]
[N03AX23, brivaracetam, Brivaracetam may decrease the excretion rate of Quinidine which could result in a higher serum level.]
[L01XX52, venetoclax, The serum concentration of Venetoclax can be increased when it is combined with Quinidine.]
[N05BA08, bromazepam, The metabolism of Bromazepam can be decreased when combined with Quinidine.]
[N04BC01, bromocriptine, Quinidine may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Bromocriptine.]
[A02AD05, aluminum magnesium silicate, Almasilate may decrease the excretion rate of Quinidine which could result in a higher serum level.]
[A02AB03, aluminum phosphate, Aluminium phosphate may decrease the excretion rate of Quinidine which could result in a higher serum level.]
[A03AX08, alverine, Alverine may increase the central nervous system depressant (CNS depressant) activities of Quinidine.]
[R06AB01, brompheniramine, Dexbrompheniramine may increase the central nervous system depressant (CNS depressant) activities of Quinidine.]
[N06AA19, amineptin, Amineptine may increase the central nervous system depressant (CNS depressant) activities of Quinidine.]
[C08CA01, amlodipine, Amlodipine may increase the arrhythmogenic activities of Quinidine.]
[N05AX17, pimavanserin, The metabolism of Quinidine can be decreased when combined with Pimavanserin.]
[N06BX11, aniracetam, Aniracetam may increase the central nervous system depressant (CNS depressant) activities of Quinidine.]
[A05AA04, obeticholic acid, The risk or severity of adverse effects can be increased when Quinidine is combined with Obeticholic acid.]
[C03CA02, bumetanide, Bumetanide may decrease the excretion rate of Quinidine which could result in a higher serum level.]
[N01BB01, bupivacaine, The risk or severity of methemoglobinemia can be increased when Quinidine is combined with Bupivacaine.]
[C07AA19, bupranolol, Quinidine may increase the arrhythmogenic activities of Bupranolol.]
[N07BC01, buprenorphine, The risk or severity of adverse effects can be increased when Quinidine is combined with Buprenorphine.]
[L02AE01, buserelin, The risk or severity of QTc prolongation can be increased when Buserelin is combined with Quinidine.]
[N05BE01, buspirone, The metabolism of Quinidine can be decreased when combined with Buspirone.]
[L01AB01, busulfan, The metabolism of Busulfan can be decreased when combined with Quinidine.]
[L01XX27, arsenic trioxide, The serum concentration of Quinidine can be increased when it is combined with Arsenic trioxide.]
[N06DA03, rivastigmine, The therapeutic efficacy of Quinidine can be decreased when used in combination with Rivastigmine.]
[P01BE02, artemether, The risk or severity of QTc prolongation can be increased when Quinidine is combined with Artemether.]
[M02AA03, clofezone, Rabeprazole may decrease the excretion rate of Quinidine which could result in a higher serum level.]
[N02AF01, butorphanol, The risk or severity of adverse effects can be increased when Quinidine is combined with Butorphanol.]
[J01MA09, sparfloxacin, The risk or severity of QTc prolongation can be increased when Quinidine is combined with Sparfloxacin.]
[R06AX09, azatadine, The risk or severity of QTc prolongation can be increased when Azatadine is combined with Quinidine.]
[S01GX07, azelastine, The metabolism of Azelastine can be decreased when combined with Quinidine.]
[L01XK03, rucaparib, The metabolism of Quinidine can be decreased when combined with Rucaparib.]
[S01AA26, azithromycin, The serum concentration of Quinidine can be increased when it is combined with Azithromycin.]
[A06AX07, plecanatide, The therapeutic efficacy of Plecanatide can be decreased when used in combination with Quinidine.]
[L01EF02, ribociclib, The metabolism of Quinidine can be decreased when combined with Ribociclib.]
[A07EC04, balsalazide, Balsalazide may decrease the excretion rate of Quinidine which could result in a higher serum level.]
[R03CC12, bambuterol, The therapeutic efficacy of Bambuterol can be decreased when used in combination with Quinidine.]
[R03DA08, bamifylline, The serum concentration of Bamifylline can be increased when it is combined with Quinidine.]
[A06AH05, naldemedine, Naldemedine may decrease the excretion rate of Quinidine which could result in a higher serum level.]
[N07XX16, deutetrabenazine, The serum concentration of the active metabolites of Deutetrabenazine can be increased when Deutetrabenazine is used in combination with Quinidine.]
[N02BF02, pregabalin, Pregabalin may decrease the excretion rate of Quinidine which could result in a higher serum level.]
[N03AX30, beclamide, Beclamide may increase the central nervous system depressant (CNS depressant) activities of Quinidine.]
[N06BC01, caffeine, The serum concentration of Caffeine can be increased when it is combined with Quinidine.]
[C09AA07, benazepril, Quinidine may decrease the antihypertensive activities of Benazepril.]
[S01HA02, benoxinate, The risk or severity of methemoglobinemia can be increased when Quinidine is combined with Oxybuprocaine.]
[D05AX03, calcitriol, The metabolism of Quinidine can be increased when combined with Calcitriol.]
[A12AA04, calcium carbonate, Calcium carbonate may decrease the excretion rate of Quinidine which could result in a higher serum level.]
[P01CA02, benznidazole, Benznidazole may decrease the excretion rate of Quinidine which could result in a higher serum level.]
[J01XX08, linezolid, The risk or severity of hypertension can be increased when Linezolid is combined with Quinidine.]
[J05AF06, abacavir, Abacavir may decrease the excretion rate of Quinidine which could result in a higher serum level.]
[J05AE09, tipranavir, The risk or severity of torsade de pointes and Cardiac Arrhythmia can be increased when Tipranavir is combined with Quinidine.]
[N07XX13, valbenazine, The metabolism of Valbenazine can be decreased when combined with Quinidine.]
[L04AB02, infliximab, The metabolism of Quinidine can be increased when combined with Infliximab.]
[L01EX10, midostaurin, The metabolism of Quinidine can be decreased when combined with Midostaurin.]
[L01ED04, brigatinib, The metabolism of Brigatinib can be decreased when combined with Quinidine.]
[N04BD03, safinamide, Safinamide may increase the central nervous system depressant (CNS depressant) activities of Quinidine.]
[L04AC14, sarilumab, The metabolism of Quinidine can be increased when combined with Sarilumab.]
[J01MA23, delafloxacin, Delafloxacin may decrease the excretion rate of Quinidine which could result in a higher serum level.]
[B01AF04, betrixaban, The serum concentration of Betrixaban can be increased when it is combined with Quinidine.]
[D01AC10, bifonazole, The metabolism of Quinidine can be decreased when combined with Bifonazole.]
[P03AC02, bioallethrin, Quinidine may increase the arrhythmogenic activities of Bioallethrin.]
[S01EB09, acetylcholine, The risk or severity of adverse effects can be increased when Quinidine is combined with Acetylcholine.]
[L01BC06, capecitabine, The metabolism of Capecitabine can be decreased when combined with Quinidine.]
[L01XX59, enasidenib, The serum concentration of Quinidine can be increased when it is combined with Enasidenib.]
[L01EH02, neratinib, The serum concentration of Quinidine can be increased when it is combined with Neratinib.]
[L01FB01, inotuzumab ozogamicin, The serum concentration of Inotuzumab ozogamicin can be increased when it is combined with Quinidine.]
[L01XH01, vorinostat, The risk or severity of QTc prolongation can be increased when Vorinostat is combined with Quinidine.]
[L01EM02, copanlisib, The serum concentration of Copanlisib can be increased when it is combined with Quinidine.]
[L01EF03, abemaciclib, The serum concentration of Abemaciclib can be increased when it is combined with Quinidine.]
[A02BX12, bismuth subnitrate, Bismuth subnitrate may decrease the excretion rate of Quinidine which could result in a higher serum level.]
[C07AB07, bisoprolol, The therapeutic efficacy of Quinidine can be increased when used in combination with Bisoprolol.]
[R03AC17, bitolterol, The therapeutic efficacy of Bitolterol can be decreased when used in combination with Quinidine.]
[J05AG03, efavirenz, The metabolism of Quinidine can be decreased when combined with Efavirenz.]
[J01DC10, cefprozil, Cefprozil may decrease the excretion rate of Quinidine which could result in a higher serum level.]
[C07AA17, bopindolol, The metabolism of Bopindolol can be decreased when combined with Quinidine.]
[N04AA11, bornaprine, The risk or severity of adverse effects can be increased when Quinidine is combined with Bornaprine.]
[N05AD06, bromperidol, Bromperidol may increase the central nervous system depressant (CNS depressant) activities of Quinidine.]
[N05CD09, brotizolam, Brotizolam may increase the central nervous system depressant (CNS depressant) activities of Quinidine.]
[C03DA03, canrenone, Canrenone may increase the excretion rate of Quinidine which could result in a lower serum level and potentially a reduction in efficacy.]
[R03BA02, budesonide, The metabolism of Quinidine can be increased when combined with Budesonide.]
[C04AX20, buflomedil, The risk or severity of hypertension can be increased when Quinidine is combined with Buflomedil.]
[M01AB07, bumadizone, Bumadizone may decrease the excretion rate of Quinidine which could result in a higher serum level.]
[L01EL02, acalabrutinib, The metabolism of Acalabrutinib can be decreased when combined with Quinidine.]
[N05CA03, butobarbital, Butobarbital may increase the central nervous system depressant (CNS depressant) activities of Quinidine.]
[J05AX18, letermovir, The metabolism of Quinidine can be decreased when combined with Letermovir.]
[N06AA15, butriptyline, The risk or severity of QTc prolongation can be increased when Butriptyline is combined with Quinidine.]
[C01AA02, acetyldigoxins, The serum concentration of Acetyldigoxin can be increased when it is combined with Quinidine.]
[N01BX04, capsaicin, The risk or severity of methemoglobinemia can be increased when Quinidine is combined with Capsaicin.]
[A10BK04, ertugliflozin, The serum concentration of Ertugliflozin can be increased when it is combined with Quinidine.]
[N05CA08, butylvinal, Vinylbital may increase the central nervous system depressant (CNS depressant) activities of Quinidine.]
[R06AX18, acrivastine, Acrivastine may decrease the excretion rate of Quinidine which could result in a higher serum level.]
[C09AA01, captopril, The excretion of Captopril can be decreased when combined with Quinidine.]
[V04CD06, macimorelin, The therapeutic efficacy of Macimorelin can be decreased when used in combination with Quinidine.]
[L02BB05, apalutamide, The serum concentration of Quinidine can be decreased when it is combined with Apalutamide.]
[N03AF01, carbamazepine, The metabolism of Quinidine can be increased when combined with Carbamazepine.]
[A06AC08, calcium polycarbophil, The therapeutic efficacy of Calcium polycarbophil can be decreased when used in combination with Quinidine.]
[A03AA03, camylofine, The risk or severity of adverse effects can be increased when Quinidine is combined with Camylofin.]
[R06AA08, carbinoxamine, The risk or severity of QTc prolongation can be increased when Carbinoxamine is combined with Quinidine.]
[C07AG02, carvedilol, Quinidine may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Carvedilol.]
[B02BX09, fostamatinib, The metabolism of Quinidine can be decreased when combined with Fostamatinib.]
[N03AX24, cannabidiol, The metabolism of Quinidine can be decreased when combined with Cannabidiol.]
[B02BX08, avatrombopag, The serum concentration of Avatrombopag can be increased when it is combined with Quinidine.]
[L04AA37, baricitinib, The serum concentration of Baricitinib can be increased when it is combined with Quinidine.]
[J01DE01, cefepime, Cefepime may decrease the excretion rate of Quinidine which could result in a higher serum level.]
[J01DD10, cefetamet, Cefetamet may decrease the excretion rate of Quinidine which could result in a higher serum level.]
[J01DD09, cefodizime, Cefodizime may decrease the excretion rate of Quinidine which could result in a higher serum level.]
[J01DC11, ceforanide, Ceforanide may decrease the excretion rate of Quinidine which could result in a higher serum level.]
[J01DD13, cefpodoxime, Cefpodoxime may decrease the excretion rate of Quinidine which could result in a higher serum level.]
[L01EC03, encorafenib, The risk or severity of QTc prolongation can be increased when Encorafenib is combined with Quinidine.]
[L01EE03, binimetinib, The serum concentration of Binimetinib can be increased when it is combined with Quinidine.]
[J01DD14, ceftibuten, Ceftibuten may decrease the excretion rate of Quinidine which could result in a higher serum level.]
[J01GB14, plazomicin, Plazomicin may decrease the excretion rate of Quinidine which could result in a higher serum level.]
[C07AB08, celiprolol, Quinidine may increase the arrhythmogenic activities of Celiprolol.]
[H01CC03, elagolix, The serum concentration of Quinidine can be increased when it is combined with Elagolix.]
[L01XX62, ivosidenib, The risk or severity of QTc prolongation can be increased when Quinidine is combined with Ivosidenib.]
[P01BA07, tafenoquine, The metabolism of Tafenoquine can be decreased when combined with Quinidine.]
[A16AX14, migalastat, Migalastat may decrease the excretion rate of Quinidine which could result in a higher serum level.]
[N03AX17, stiripentol, The metabolism of Quinidine can be decreased when combined with Stiripentol.]
[B02BX07, lusutrombopag, The serum concentration of Lusutrombopag can be increased when it is combined with Quinidine.]
[J05AX24, tecovirimat, The metabolism of Quinidine can be increased when combined with Tecovirimat.]
[L01EM04, duvelisib, The metabolism of Quinidine can be decreased when combined with Duvelisib.]
[L01EB07, dacomitinib, The serum concentration of Dacomitinib can be increased when it is combined with Quinidine.]
[J01AA14, sarecycline, The serum concentration of Quinidine can be increased when it is combined with Sarecycline.]
[J01AA15, omadacycline, The serum concentration of Omadacycline can be increased when it is combined with Quinidine.]
[S01GX12, cetirizine, Cetirizine may decrease the excretion rate of Quinidine which could result in a higher serum level.]
[N05CM04, carbromal, Carbromal may increase the central nervous system depressant (CNS depressant) activities of Quinidine.]
[A10BB06, carbutamide, The metabolism of Carbutamide can be decreased when combined with Quinidine.]
[N01BA04, chloroprocaine, The risk or severity of methemoglobinemia can be increased when Quinidine is combined with Chloroprocaine.]
[D08AE05, chloroxylenol, Chloroxylenol may decrease the excretion rate of Quinidine which could result in a higher serum level.]
[R06AA06, chlorphenoxamine, The risk or severity of adverse effects can be increased when Quinidine is combined with Chlorphenoxamine.]
[M01AC05, lornoxicam, Lornoxicam may decrease the excretion rate of Quinidine which could result in a higher serum level.]
[R03DA02, oxtriphylline, The serum concentration of Oxtriphylline can be increased when it is combined with Quinidine.]
[N07XX15, inotersen, Inotersen may decrease the excretion rate of Quinidine which could result in a higher serum level.]
[L01XK04, talazoparib, The serum concentration of Talazoparib can be increased when it is combined with Quinidine.]
[M03BA02, carisoprodol, Carisoprodol may increase the central nervous system depressant (CNS depressant) activities of Quinidine.]
[R03BB08, revefenacin, Quinidine may decrease the excretion rate of Revefenacin which could result in a higher serum level.]
[L01ED05, lorlatinib, The serum concentration of Quinidine can be decreased when it is combined with Lorlatinib.]
[L04AA39, emapalumab, The metabolism of Quinidine can be increased when combined with Emapalumab.]
[L01AD01, carmustine, The metabolism of Carmustine can be decreased when combined with Quinidine.]
[L01EX12, larotrectinib, The serum concentration of Larotrectinib can be increased when it is combined with Quinidine.]
[L01EX13, gilteritinib, The risk or severity of QTc prolongation can be increased when Gilteritinib is combined with Quinidine.]
[L01XJ03, glasdegib, The serum concentration of Quinidine can be increased when it is combined with Glasdegib.]
[N07XX05, amifampridine, The risk or severity of seizure can be increased when Quinidine is combined with Amifampridine.]
[A06AX05, prucalopride, The serum concentration of Prucalopride can be increased when it is combined with Quinidine.]
[C01BG07, cifenline, Quinidine may increase the arrhythmogenic activities of Cibenzoline.]
[C09AA08, cilazapril, Quinidine may decrease the antihypertensive activities of Cilazapril.]
[B01AC23, cilostazol, The metabolism of Cilostazol can be decreased when combined with Quinidine.]
[A03FA08, cinitapride, Cinitapride may increase the central nervous system depressant (CNS depressant) activities of Quinidine.]
[S01ED05, carteolol, Quinidine may increase the arrhythmogenic activities of Carteolol.]
[P02BX04, triclabendazole, The metabolism of Quinidine can be decreased when combined with Triclabendazole.]
[N06AX27, esketamine, The risk or severity of hypertension can be increased when Esketamine is combined with Quinidine.]
[L04AA42, siponimod, The risk or severity of adverse effects can be increased when Quinidine is combined with Siponimod.]
[J01FA09, clarithromycin, The metabolism of Quinidine can be decreased when combined with Clarithromycin.]
[N06BA14, solriamfetol, The risk or severity of hypertension can be increased when Solriamfetol is combined with Quinidine.]
[N06AX29, brexanolone, Brexanolone may increase the central nervous system depressant (CNS depressant) activities of Quinidine.]
[L01EN01, erdafitinib, The serum concentration of Quinidine can be increased when it is combined with Erdafitinib.]
[N05BA09, clobazam, The metabolism of Quinidine can be increased when combined with Clobazam.]
[J01AA11, clomocycline, The risk or severity of neuromuscular blockade can be increased when Clomocycline is combined with Quinidine.]
[H02AB14, cloprednol, The metabolism of Quinidine can be increased when combined with Cloprednol.]
[A06AB05, castor oil, The therapeutic efficacy of Castor oil can be decreased when used in combination with Quinidine.]
[N05BA22, cloxazolam, Cloxazolam may increase the central nervous system depressant (CNS depressant) activities of Quinidine.]
[C09CA06, candesartan, The metabolism of Candesartan can be decreased when combined with Quinidine.]
[L04AB01, etanercept, The metabolism of Quinidine can be increased when combined with Etanercept.]
[H02AB17, cortivazol, The metabolism of Quinidine can be increased when combined with Cortivazol.]
[L01EM03, alpelisib, The metabolism of Quinidine can be increased when combined with Alpelisib.]
[J01DC04, cefaclor, Cefaclor may decrease the excretion rate of Quinidine which could result in a higher serum level.]
[J01DB05, cefadroxil, Cefadroxil may decrease the excretion rate of Quinidine which could result in a higher serum level.]
[J01DC03, cefamandole, Cefamandole may decrease the excretion rate of Quinidine which could result in a higher serum level.]
[J01DB07, cefatrizine, Cefatrizine may decrease the excretion rate of Quinidine which could result in a higher serum level.]
[J01DB04, cefazolin, Cefazolin may decrease the excretion rate of Quinidine which could result in a higher serum level.]
[L02BB06, darolutamide, The serum concentration of Darolutamide can be increased when it is combined with Quinidine.]
[J01DC09, cefmetazole, Cefmetazole may decrease the excretion rate of Quinidine which could result in a higher serum level.]
[J01DC06, cefonicid, Cefonicid may decrease the excretion rate of Quinidine which could result in a higher serum level.]
[L01EX15, pexidartinib, The metabolism of Pexidartinib can be decreased when combined with Quinidine.]
[J01DD12, cefoperazone, Cefoperazone may decrease the excretion rate of Quinidine which could result in a higher serum level.]
[J01DD01, cefotaxime, Cefotaxime may decrease the excretion rate of Quinidine which could result in a higher serum level.]
[J01DC05, cefotetan, Cefotetan may decrease the excretion rate of Quinidine which could result in a higher serum level.]
[N05AA06, cyamemazine, The risk or severity of QTc prolongation can be increased when Quinidine is combined with Cyamemazine.]
[J01DC07, cefotiam, Cefotiam may decrease the excretion rate of Quinidine which could result in a higher serum level.]
[J01DC01, cefoxitin, Cefoxitin may decrease the excretion rate of Quinidine which could result in a higher serum level.]
[J01DD03, cefsulodin, Cefsulodin may decrease the excretion rate of Quinidine which could result in a higher serum level.]
[J01DD02, ceftazidime, Ceftazidime may decrease the excretion rate of Quinidine which could result in a higher serum level.]
[C03BX03, cicletanine, Quinidine may increase the arrhythmogenic activities of Cicletanine.]
[J01DD07, ceftizoxime, Ceftizoxime may decrease the excretion rate of Quinidine which could result in a higher serum level.]
[J01DD04, ceftriaxone, Ceftriaxone may decrease the excretion rate of Quinidine which could result in a higher serum level.]
[S01AA27, cefuroxime, Cefuroxime may decrease the excretion rate of Quinidine which could result in a higher serum level.]
[M03BX08, cyclobenzaprine, The metabolism of Cyclobenzaprine can be decreased when combined with Quinidine.]
[L01EJ02, fedratinib, The serum concentration of Quinidine can be increased when it is combined with Fedratinib.]
[L01EX14, entrectinib, The risk or severity of QTc prolongation can be increased when Quinidine is combined with Entrectinib.]
[N07XX11, pitolisant, The serum concentration of Pitolisant can be increased when it is combined with Quinidine.]
[J04AK08, pretomanid, The metabolism of Quinidine can be decreased when combined with Pretomanid.]
[J01XX12, lefamulin, Lefamulin may increase the QTc-prolonging activities of Quinidine.]
[N04CX01, istradefylline, The serum concentration of Quinidine can be increased when it is combined with Istradefylline.]
[C03AA09, cyclothiazide, Cyclothiazide may increase the excretion rate of Quinidine which could result in a lower serum level and potentially a reduction in efficacy.]
[G04BE04, yohimbine, The metabolism of Yohimbine can be decreased when combined with Quinidine.]
[A06AB03, danthron, The therapeutic efficacy of Dantron can be decreased when used in combination with Quinidine.]
[J01XX09, daptomycin, Daptomycin may decrease the excretion rate of Quinidine which could result in a higher serum level.]
[J01DB01, cephalexin, Cephalexin may decrease the excretion rate of Quinidine which could result in a higher serum level.]
[J01DB02, cephaloridine, Cefaloridine may decrease the excretion rate of Quinidine which could result in a higher serum level.]
[J01DB03, cephalothin, Cefalotin may decrease the excretion rate of Quinidine which could result in a higher serum level.]
[J01DB08, cephapirin, Cefapirin may decrease the excretion rate of Quinidine which could result in a higher serum level.]
[J01DB09, cephradine, The metabolism of Quinidine can be increased when combined with Cefradine.]
[H02AB13, deflazacort, The metabolism of Quinidine can be increased when combined with Deflazacort.]
[L01FD03, ado-trastuzumab emtansine, The serum concentration of Trastuzumab emtansine can be increased when it is combined with Quinidine.]
[N02CC08, lasmiditan, The serum concentration of Quinidine can be increased when it is combined with Lasmiditan.]
[L01EL03, zanubrutinib, The metabolism of Zanubrutinib can be decreased when combined with Quinidine.]
[G03AC09, desogestrel, The metabolism of Desogestrel can be decreased when combined with Quinidine.]
[B06AX03, voxelotor, The serum concentration of Quinidine can be increased when it is combined with Voxelotor.]
[N03AX25, cenobamate, The serum concentration of Quinidine can be decreased when it is combined with Cenobamate.]
[A16AX16, givosiran, Givosiran may decrease the excretion rate of Quinidine which could result in a higher serum level.]
[M09AX08, golodirsen, Golodirsen may decrease the excretion rate of Quinidine which could result in a higher serum level.]
[N02CD04, ubrogepant, The serum concentration of Ubrogepant can be increased when it is combined with Quinidine.]
[L01FX13, enfortumab vedotin, The serum concentration of Enfortumab vedotin can be increased when it is combined with Quinidine.]
[R06AB06, dexbrompheniramine, Dexbrompheniramine may increase the central nervous system depressant (CNS depressant) activities of Quinidine.]
[R06AB02, dexchlorpheniramine, The risk or severity of QTc prolongation can be increased when Dexchlorpheniramine is combined with Quinidine.]
[S01XA12, dexpanthenol, Dexpanthenol may decrease the excretion rate of Quinidine which could result in a higher serum level.]
[N02AX03, dezocine, The risk or severity of adverse effects can be increased when Quinidine is combined with Dezocine.]
[L01EX18, avapritinib, The metabolism of Avapritinib can be decreased when combined with Quinidine.]
[N05CM21, lemborexant, The serum concentration of Lemborexant can be increased when it is combined with Quinidine.]
[L01XX72, tazemetostat, The metabolism of Quinidine can be decreased when combined with Tazemetostat.]
[N05AD10, lumateperone, Lumateperone may increase the central nervous system depressant (CNS depressant) activities of Quinidine.]
[N02CD06, rimegepant, The serum concentration of Rimegepant can be increased when it is combined with Quinidine.]
[J05AB16, remdesivir, The metabolism of Quinidine can be decreased when combined with Remdesivir.]
[S01AE06, gatifloxacin, The risk or severity of QTc prolongation can be increased when Gatifloxacin is combined with Quinidine.]
[H02CA02, osilodrostat, The metabolism of Quinidine can be decreased when combined with Osilodrostat.]
[J05AE05, amprenavir, The metabolism of Quinidine can be decreased when combined with Amprenavir.]
[N02CC07, frovatriptan, The metabolism of Frovatriptan can be decreased when combined with Quinidine.]
[G04CB02, dutasteride, The risk or severity of hypertension can be increased when Quinidine is combined with Dutasteride.]
[L04AA38, ozanimod, The metabolism of Ozanimod can be decreased when combined with Quinidine.]
[N05CC04, dichloralphenazone, Dichloralphenazone may increase the central nervous system depressant (CNS depressant) activities of Quinidine.]
[L01EE04, selumetinib, The metabolism of Selumetinib can be decreased when combined with Quinidine.]
[R02AA03, dichlorobenzyl alcohol, Dichlorobenzyl alcohol may decrease the excretion rate of Quinidine which could result in a higher serum level.]
[G03DB08, dienogest, Dienogest may decrease the excretion rate of Quinidine which could result in a higher serum level.]
[A07DA04, difenoxin, Difenoxin may increase the central nervous system depressant (CNS depressant) activities of Quinidine.]
[N02AA08, dihydrocodeine, The risk or severity of adverse effects can be increased when Quinidine is combined with Dihydrocodeine.]
[N02CC06, eletriptan, The metabolism of Eletriptan can be decreased when combined with Quinidine.]
[M01AH02, rofecoxib, The metabolism of Quinidine can be increased when combined with Rofecoxib.]
[L01XF03, bexarotene, The metabolism of Quinidine can be increased when combined with Bexarotene.]
[C08CA16, clevidipine, Quinidine may increase the arrhythmogenic activities of Clevidipine.]
[C01BD07, dronedarone, Quinidine may increase the QTc-prolonging activities of Dronedarone.]
[N03AG02, dipropylacetamide, Valpromide may increase the central nervous system depressant (CNS depressant) activities of Quinidine.]
[J01FA13, dirithromycin, The serum concentration of Quinidine can be increased when it is combined with Dirithromycin.]
[S03AA08, chloramphenicol, The metabolism of Quinidine can be decreased when combined with Chloramphenicol.]
[R06AE04, chlorcyclizine, The risk or severity of QTc prolongation can be increased when Chlorcyclizine is combined with Quinidine.]
[N05BA02, chlordiazepoxide, Chlordiazepoxide may increase the central nervous system depressant (CNS depressant) activities of Quinidine.]
[C02AA06, methoserpidine, Quinidine may decrease the antihypertensive activities of Methoserpidine.]
[L01EH03, tucatinib, Tucatinib may decrease the excretion rate of Quinidine which could result in a higher serum level.]
[A03AA08, dihexyverine, The risk or severity of adverse effects can be increased when Quinidine is combined with Dihexyverine.]
[L01EX17, capmatinib, The serum concentration of Capmatinib can be increased when it is combined with Quinidine.]
[N04BX04, opicapone, The serum concentration of Opicapone can be decreased when it is combined with Quinidine.]
[C01CA14, dopexamine, The therapeutic efficacy of Dopexamine can be decreased when used in combination with Quinidine.]
[D07XB03, fluprednidene, The metabolism of Quinidine can be increased when combined with Fluprednidene.]
[G04BD09, trospium, The risk or severity of adverse effects can be increased when Trospium is combined with Quinidine.]
[M01AC04, droxicam, Droxicam may decrease the excretion rate of Quinidine which could result in a higher serum level.]
[L01EX19, ripretinib, The serum concentration of Quinidine can be increased when it is combined with Ripretinib.]
[V08CA05, mangafodipir, Mangafodipir may decrease the excretion rate of Quinidine which could result in a higher serum level.]
[L01EX22, selpercatinib, The serum concentration of Selpercatinib can be increased when it is combined with Quinidine.]
[B01AE02, lepirudin, The therapeutic efficacy of Lepirudin can be increased when used in combination with Quinidine.]
[M02AA27, dexketoprofen, Dexketoprofen may decrease the excretion rate of Quinidine which could result in a higher serum level.]
[N05CM02, chlormethiazole, Clomethiazole may increase the central nervous system depressant (CNS depressant) activities of Quinidine.]
[M03BB02, chlormezanone, Chlormezanone may increase the central nervous system depressant (CNS depressant) activities of Quinidine.]
[R02AD04, dyclonine, The risk or severity of methemoglobinemia can be increased when Quinidine is combined with Dyclonine.]
[C08CA17, levamlodipine, The serum concentration of Levamlodipine can be increased when it is combined with Quinidine.]
[R06AX22, ebastine, The metabolism of Quinidine can be decreased when combined with Ebastine.]
[J05AX29, fostemsavir, The risk or severity of QTc prolongation can be increased when Fostemsavir is combined with Quinidine.]
[P01BB01, proguanil, The metabolism of Proguanil can be decreased when combined with Quinidine.]
[N05CD14, remimazolam, Remimazolam may increase the central nervous system depressant (CNS depressant) activities of Quinidine.]
[L01FX15, belantamab mafodotin, Quinidine may decrease the excretion rate of Belantamab mafodotin which could result in a higher serum level.]
[L04AC19, satralizumab, The serum concentration of Quinidine can be decreased when it is combined with Satralizumab.]
[N02AX07, oliceridine, The serum concentration of Oliceridine can be increased when it is combined with Quinidine.]
[P01BA01, chloroquine, The risk or severity of QTc prolongation can be increased when Chloroquine is combined with Quinidine.]
[L01EX23, pralsetinib, The serum concentration of Pralsetinib can be increased when it is combined with Quinidine.]
[C03AA04, chlorothiazide, Chlorothiazide may increase the excretion rate of Quinidine which could result in a lower serum level and potentially a reduction in efficacy.]
[R06AB04, chlorpheniramine, The metabolism of Quinidine can be decreased when combined with Chlorpheniramine.]
[N05AA01, chlorpromazine, Chlorpromazine may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Quinidine.]
[A10BB02, chlorpropamide, Chlorpropamide may decrease the excretion rate of Quinidine which could result in a higher serum level.]
[N05AF03, chlorprothixene, Chlorprothixene may increase the central nervous system depressant (CNS depressant) activities of Quinidine.]
[C03BA04, chlorthalidone, Chlorthalidone may increase the excretion rate of Quinidine which could result in a lower serum level and potentially a reduction in efficacy.]
[M03BB03, chlorzoxazone, The metabolism of Chlorzoxazone can be decreased when combined with Quinidine.]
[V04CK02, cholecystokinin, The excretion of Cholecystokinin can be decreased when combined with Quinidine.]
[N05BX03, etifoxine, Etifoxine may increase the central nervous system depressant (CNS depressant) activities of Quinidine.]
[N02BA07, ethenzamide, Ethenzamide may decrease the excretion rate of Quinidine which could result in a higher serum level.]
[N02BA03, choline salicylate, Choline salicylate may decrease the excretion rate of Quinidine which could result in a higher serum level.]
[N06BX18, vinpocetine, Quinidine may increase the arrhythmogenic activities of Vinpocetine.]
[N05BA18, ethyl loflazepate, Ethyl loflazepate may increase the central nervous system depressant (CNS depressant) activities of Quinidine.]
[M01AB08, etodolac, Etodolac may decrease the excretion rate of Quinidine which could result in a higher serum level.]
[M02AA06, etofenamate, Etofenamate may decrease the excretion rate of Quinidine which could result in a higher serum level.]
[B06AC06, berotralstat, The serum concentration of Berotralstat can be increased when it is combined with Quinidine.]
[A16AX20, lonafarnib, The metabolism of Quinidine can be decreased when combined with Lonafarnib.]
[M09AA01, hydroquinine, Quinidine may increase the arrhythmogenic activities of Hydroquinine.]
[L02BX04, relugolix, The serum concentration of Relugolix can be increased when it is combined with Quinidine.]
[M01AX25, chondroitin sulfates, Chondroitin sulfate may decrease the excretion rate of Quinidine which could result in a higher serum level.]
[L01FX21, naxitamab, The risk or severity of hypertension can be increased when Quinidine is combined with Naxitamab.]
[L04AD03, voclosporin, The serum concentration of Quinidine can be increased when it is combined with Voclosporin.]
[P03AX07, abametapir, The serum concentration of Quinidine can be increased when it is combined with Abametapir.]
[L01EX21, tepotinib, The serum concentration of Tepotinib can be increased when it is combined with Quinidine.]
[L01EX25, umbralisib, The serum concentration of Quinidine can be increased when it is combined with Umbralisib.]
[V03AF12, trilaciclib, The serum concentration of Trilaciclib can be increased when it is combined with Quinidine.]
[M03BA05, febarbamate, Febarbamate may increase the central nervous system depressant (CNS depressant) activities of Quinidine.]
[N03AX10, felbamate, The metabolism of Quinidine can be increased when combined with Felbamate.]
[M01AE05, fenbufen, Fenbufen may decrease the excretion rate of Quinidine which could result in a higher serum level.]
[N06BA10, fenethylline, The serum concentration of Fenethylline can be increased when it is combined with Quinidine.]
[C01CA19, fenoldopam, Fenoldopam may decrease the excretion rate of Quinidine which could result in a higher serum level.]
[N06BA08, fenozolone, The risk or severity of hypertension can be increased when Quinidine is combined with Fenozolone.]
[G04CB01, finasteride, The metabolism of Quinidine can be decreased when combined with Finasteride.]
[J01DD15, cefdinir, Cefdinir may decrease the excretion rate of Quinidine which could result in a higher serum level.]
[J01MB07, flumequine, The risk or severity of QTc prolongation can be increased when Flumequine is combined with Quinidine.]
[R03BA03, flunisolide, The metabolism of Quinidine can be increased when combined with Flunisolide.]
[S02BA08, fluocinolone acetonide, The metabolism of Quinidine can be increased when combined with Fluocinolone acetonide.]
[S01JA01, fluorescein, Quinidine may decrease the excretion rate of Fluorescein which could result in a higher serum level.]
[N02BG07, flupirtine, Flupirtine may decrease the excretion rate of Quinidine which could result in a higher serum level.]
[R03CC15, formoterol, The metabolism of Formoterol can be decreased when combined with Quinidine.]
[L04AA50, ponesimod, The risk or severity of bradycardia can be increased when Ponesimod is combined with Quinidine.]
[L01EK03, tivozanib, The serum concentration of Tivozanib can be increased when it is combined with Quinidine.]
[N01AB05, trichloroethylene, Trichloroethylene may increase the central nervous system depressant (CNS depressant) activities of Quinidine.]
[H04AA02, dasiglucagon, Quinidine may decrease the antihypertensive activities of Dasiglucagon.]
[L01FX22, loncastuximab tesirine, The serum concentration of Loncastuximab tesirine can be increased when it is combined with Quinidine.]
[A02BA01, cimetidine, The metabolism of Quinidine can be decreased when combined with Cimetidine.]
[N02BF01, gabapentin, Gabapentin may increase the central nervous system depressant (CNS depressant) activities of Quinidine.]
[V08CA04, gadoteridol, Gadoteridol may decrease the excretion rate of Quinidine which could result in a higher serum level.]
[N07CA02, cinnarizine, Cinnarizine may increase the arrhythmogenic activities of Quinidine.]
[J01MB06, cinoxacin, The risk or severity of QTc prolongation can be increased when Cinoxacin is combined with Quinidine.]
[L01XX73, sotorasib, The serum concentration of Quinidine can be decreased when it is combined with Sotorasib.]
[L01EN03, infigratinib, The metabolism of Quinidine can be decreased when combined with Infigratinib.]
[S03AA07, ciprofloxacin, The metabolism of Quinidine can be decreased when combined with Ciprofloxacin.]
[L01XA01, cisplatin, The serum concentration of Cisplatin can be increased when it is combined with Quinidine.]
[N06AB04, citalopram, The metabolism of Quinidine can be decreased when combined with Citalopram.]
[C03DA05, finerenone, The serum concentration of Finerenone can be increased when it is combined with Quinidine.]
[L04AA48, belumosudil, The serum concentration of Quinidine can be increased when it is combined with Belumosudil.]
[P01CA03, fexinidazole, The risk or severity of adverse effects can be increased when Quinidine is combined with Fexinidazole.]
[L01XX74, belzutifan, The serum concentration of Quinidine can be decreased when it is combined with Belzutifan.]
[L01EB10, mobocertinib, The risk or severity of QTc prolongation can be increased when Quinidine is combined with Mobocertinib.]
[N02CD07, atogepant, The serum concentration of Atogepant can be increased when it is combined with Quinidine.]
[V09AB03, ioflupane I-123, Ioflupane I-123 may decrease the excretion rate of Quinidine which could result in a higher serum level.]
[V09GA01, technetium Tc 99m sestamibi, The serum concentration of Technetium Tc-99m sestamibi can be increased when it is combined with Quinidine.]
[V09AA01, technetium Tc 99m exametazime, Technetium Tc-99m exametazime may decrease the excretion rate of Quinidine which could result in a higher serum level.]
[V09AX06, florbetaben f-18, Florbetaben (18F) may decrease the excretion rate of Quinidine which could result in a higher serum level.]
[L04AA59, avacopan, The metabolism of Quinidine can be decreased when combined with Avacopan.]
[R06AA04, clemastine, The risk or severity of QTc prolongation can be increased when Clemastine is combined with Quinidine.]
[M01AG01, mefenamic acid, The metabolism of Mefenamic acid can be decreased when combined with Quinidine.]
[A10BB12, glimepiride, Quinidine may decrease the excretion rate of Glimepiride which could result in a higher serum level.]
[A10BB08, gliquidone, The metabolism of Gliquidone can be decreased when combined with Quinidine.]
[R03CC13, clenbuterol, The therapeutic efficacy of Clenbuterol can be decreased when used in combination with Quinidine.]
[J01FF01, clindamycin, The metabolism of Clindamycin can be decreased when combined with Quinidine.]
[N06AX25, St. John's wort extract, The serum concentration of Quinidine can be decreased when it is combined with St. John's Wort.]
[L01EA06, asciminib, The serum concentration of Quinidine can be increased when it is combined with Asciminib.]
[J05AX10, maribavir, The serum concentration of Quinidine can be increased when it is combined with Maribavir.]
[D11AH08, abrocitinib, The serum concentration of Quinidine can be increased when it is combined with Abrocitinib.]
[J04BA01, clofazimine, The serum concentration of Quinidine can be increased when it is combined with Clofazimine.]
[B01AD11, tenecteplase, The therapeutic efficacy of Tenecteplase can be increased when used in combination with Quinidine.]
[C10AB01, clofibrate, The metabolism of Quinidine can be increased when combined with Clofibrate.]
[B06AX04, mitapivat, The metabolism of Quinidine can be increased when combined with Mitapivat.]
[N01BB10, levobupivacaine, The risk or severity of methemoglobinemia can be increased when Quinidine is combined with Levobupivacaine.]
[L01EJ03, pacritinib, The serum concentration of Quinidine can be increased when it is combined with Pacritinib.]
[G03GB02, clomiphene, The serum concentration of Clomifene can be increased when it is combined with Quinidine.]
[N06AA04, clomipramine, The metabolism of Clomipramine can be decreased when combined with Quinidine.]
[N03AE01, clonazepam, Clonazepam may decrease the excretion rate of Quinidine which could result in a higher serum level.]
[S01EA04, clonidine, The metabolism of Clonidine can be decreased when combined with Quinidine.]
[J05AB17, brincidofovir, The serum concentration of Brincidofovir can be increased when it is combined with Quinidine.]
[C01EB24, mavacamten, The serum concentration of Quinidine can be decreased when it is combined with Mavacamten.]
[J05AH02, oseltamivir, Oseltamivir may decrease the excretion rate of Quinidine which could result in a higher serum level.]
[C03BA03, clopamide, Clopamide may increase the excretion rate of Quinidine which could result in a lower serum level and potentially a reduction in efficacy.]
[A05BA08, glycyrrhizic acid, Quinidine may decrease the excretion rate of Glycyrrhizic acid which could result in a higher serum level.]
[N05AH06, clothiapine, Clothiapine may increase the central nervous system depressant (CNS depressant) activities of Quinidine.]
[N05BA21, clotiazepam, Clotiazepam may increase the central nervous system depressant (CNS depressant) activities of Quinidine.]
[A04AA01, ondansetron, The metabolism of Quinidine can be decreased when combined with Ondansetron.]
[A04AA02, granisetron, The risk or severity of QTc prolongation can be increased when Granisetron is combined with Quinidine.]
[J05AX31, lenacapavir, The metabolism of Quinidine can be decreased when combined with Lenacapavir.]
[N05AH02, clozapine, The serum concentration of Clozapine can be increased when it is combined with Quinidine.]
[L01EN04, futibatinib, The serum concentration of Futibatinib can be increased when it is combined with Quinidine.]
[A10BK06, sotagliflozin, The serum concentration of Quinidine can be increased when it is combined with Sotagliflozin.]
[J01GB12, arbekacin, Arbekacin may decrease the excretion rate of Quinidine which could result in a higher serum level.]
[N05BA13, halazepam, Halazepam may increase the central nervous system depressant (CNS depressant) activities of Quinidine.]
[H01AC08, somatrogon, The metabolism of Quinidine can be increased when combined with Somatrogon.]
[S02DA02, cocaine, The risk or severity of methemoglobinemia can be increased when Quinidine is combined with Cocaine.]
[C02KB01, metyrosine, Quinidine may decrease the antihypertensive activities of Metyrosine.]
[L04AC21, bimekizumab, The metabolism of Quinidine can be increased when combined with Bimekizumab.]
[M01AX13, proquazone, Proquazone may decrease the excretion rate of Quinidine which could result in a higher serum level.]
[R05DA04, codeine, The risk or severity of adverse effects can be increased when Quinidine is combined with Codeine.]
[M03AC05, hexafluorenium, Hexafluronium may increase the central nervous system depressant (CNS depressant) activities of Quinidine.]
[M04AC01, colchicine, The serum concentration of Colchicine can be increased when it is combined with Quinidine.]
[A03AB10, hexocyclium, The risk or severity of adverse effects can be increased when Quinidine is combined with Hexocyclium.]
[A03BB06, homatropine methylbromide, The risk or severity of adverse effects can be increased when Homatropine methylbromide is combined with Quinidine.]
[S01FA05, homatropine, The risk or severity of adverse effects can be increased when Quinidine is combined with Homatropine.]
[J01XB01, colistin, Colistin may decrease the excretion rate of Quinidine which could result in a higher serum level.]
[J01DE02, cefpirome, Cefpirome may decrease the excretion rate of Quinidine which could result in a higher serum level.]
[L04AA13, leflunomide, The metabolism of Leflunomide can be decreased when combined with Quinidine.]
[C01BA13, hydroquinidine, Quinidine may increase the arrhythmogenic activities of Hydroquinidine.]
[A02AD04, hydrotalcite, Hydrotalcite may decrease the excretion rate of Quinidine which could result in a higher serum level.]
[N01AB07, desflurane, Desflurane may increase the central nervous system depressant (CNS depressant) activities of Quinidine.]
[A04AA03, tropisetron, Quinidine may increase the arrhythmogenic activities of Tropisetron.]
[C04AX28, ifenprodil, Ifenprodil may increase the central nervous system depressant (CNS depressant) activities of Quinidine.]
[A10BX03, nateglinide, The metabolism of Quinidine can be decreased when combined with Nateglinide.]
[N02BA16, imidazole-2-hydroxybenzoate, Imidazole salicylate may decrease the excretion rate of Quinidine which could result in a higher serum level.]
[J01FA15, telithromycin, The metabolism of Quinidine can be decreased when combined with Telithromycin.]
[R03BA08, ciclesonide, The metabolism of Ciclesonide can be decreased when combined with Quinidine.]
[B01AC10, indobufen, Indobufen may decrease the excretion rate of Quinidine which could result in a higher serum level.]
[R06AX27, desloratadine, The risk or severity of QTc prolongation can be increased when Desloratadine is combined with Quinidine.]
[J05AB14, valganciclovir, Valganciclovir may decrease the excretion rate of Quinidine which could result in a higher serum level.]
[C05BB03, invert sugar, Invert sugar may decrease the excretion rate of Quinidine which could result in a higher serum level.]
[V08AB09, iodixanol, Iodixanol may decrease the excretion rate of Quinidine which could result in a higher serum level.]
[V08AB05, iopromide, Iopromide may decrease the excretion rate of Quinidine which could result in a higher serum level.]
[V08AB07, ioversol, Ioversol may decrease the excretion rate of Quinidine which could result in a higher serum level.]
[V08AB12, ioxilan, Ioxilan may decrease the excretion rate of Quinidine which could result in a higher serum level.]
[M01AH03, valdecoxib, Valdecoxib may decrease the excretion rate of Quinidine which could result in a higher serum level.]
[H01AX01, pegvisomant, The therapeutic efficacy of Quinidine can be decreased when used in combination with Pegvisomant.]
[C01AA06, lanatoside C, The serum concentration of Lanatoside C can be increased when it is combined with Quinidine.]
[A03AX10, isometheptene, The therapeutic efficacy of Isometheptene can be decreased when used in combination with Quinidine.]
[N02CC05, almotriptan, The metabolism of Almotriptan can be decreased when combined with Quinidine.]
[M01AH04, parecoxib, Parecoxib may decrease the excretion rate of Quinidine which could result in a higher serum level.]
[J02AC02, itraconazole, The metabolism of Quinidine can be decreased when combined with Itraconazole.]
[B01AB12, bemiparin, The therapeutic efficacy of Bemiparin can be increased when used in combination with Quinidine.]
[S01AD03, acyclovir, The metabolism of Acyclovir can be decreased when combined with Quinidine.]
[S01GX06, emedastine, The risk or severity of QTc prolongation can be increased when Emedastine is combined with Quinidine.]
[N05BA10, ketazolam, The metabolism of Quinidine can be decreased when combined with Ketazolam.]
[M01AA06, kebuzone, Kebuzone may decrease the excretion rate of Quinidine which could result in a higher serum level.]
[L01EA01, imatinib, The serum concentration of Quinidine can be increased when it is combined with Imatinib.]
[J02AC04, posaconazole, The metabolism of Quinidine can be decreased when combined with Posaconazole.]
[C08CA09, lacidipine, Quinidine may increase the arrhythmogenic activities of Lacidipine.]
[A06AD12, lactitol, The therapeutic efficacy of Lactitol can be decreased when used in combination with Quinidine.]
[N03AX09, lamotrigine, Lamotrigine may increase the arrhythmogenic activities of Quinidine.]
[S01GX02, levocabastine, Levocabastine may increase the central nervous system depressant (CNS depressant) activities of Quinidine.]
[S01BA03, cortisone, The metabolism of Quinidine can be increased when combined with Cortisone.]
[N07BC04, lofexidine, The risk or severity of QTc prolongation can be increased when Lofexidine is combined with Quinidine.]
[S01AE04, lomefloxacin, The risk or severity of QTc prolongation can be increased when Lomefloxacin is combined with Quinidine.]
[M01AB09, lonazolac, Lonazolac may decrease the excretion rate of Quinidine which could result in a higher serum level.]
[R06AX13, loratadine, Quinidine may decrease the excretion rate of Loratadine which could result in a higher serum level.]
[N05CD06, lormetazepam, Lormetazepam may increase the central nervous system depressant (CNS depressant) activities of Quinidine.]
[M02AA31, loxoprofen, Loxoprofen may decrease the excretion rate of Quinidine which could result in a higher serum level.]
[J01DC08, loracarbef, Loracarbef may decrease the excretion rate of Quinidine which could result in a higher serum level.]
[C09AA03, lisinopril, Lisinopril may decrease the excretion rate of Quinidine which could result in a higher serum level.]
[A02AD02, magaldrate, Magaldrate may decrease the excretion rate of Quinidine which could result in a higher serum level.]
[A06AD01, magnesium carbonate, Magnesium carbonate may decrease the excretion rate of Quinidine which could result in a higher serum level.]
[B05XA10, magnesium phosphate, The risk or severity of neuromuscular blockade can be increased when Quinidine is combined with Magnesium phosphate.]
[C08CA11, manidipine, Quinidine may increase the arrhythmogenic activities of Manidipine.]
[A03AA04, mebeverine, The risk or severity of adverse effects can be increased when Quinidine is combined with Mebeverine.]
[N06AX13, medifoxamine, Medifoxamine may increase the central nervous system depressant (CNS depressant) activities of Quinidine.]
[A08AA09, mefenorex, The risk or severity of hypertension can be increased when Quinidine is combined with Mefenorex.]
[C07AA14, mepindolol, The metabolism of Mepindolol can be decreased when combined with Quinidine.]
[H02AB15, meprednisone, The metabolism of Quinidine can be increased when combined with Meprednisone.]
[R06AD07, mequitazine, The metabolism of Quinidine can be decreased when combined with Mequitazine.]
[J01DH02, meropenem, Meropenem may decrease the excretion rate of Quinidine which could result in a higher serum level.]
[C01EB10, adenosine, Adenosine may increase the arrhythmogenic activities of Quinidine.]
[N04AA03, methixene, The risk or severity of adverse effects can be increased when Metixene is combined with Quinidine.]
[C04AX01, cyclandelate, Quinidine may increase the arrhythmogenic activities of Cyclandelate.]
[R03CB02, methoxyphenamine, The therapeutic efficacy of Quinidine can be decreased when used in combination with Methoxyphenamine.]
[R06AE03, cyclizine, Cyclizine may increase the central nervous system depressant (CNS depressant) activities of Quinidine.]
[N05CA10, cyclobarbital, Cyclobarbital may increase the central nervous system depressant (CNS depressant) activities of Quinidine.]
[C03DA04, eplerenone, The metabolism of Quinidine can be decreased when combined with Eplerenone.]
[N05AD03, metylperon, Quinidine may increase the arrhythmogenic activities of Melperone.]
[C03AA07, cyclopenthiazide, Cyclopenthiazide may increase the excretion rate of Quinidine which could result in a lower serum level and potentially a reduction in efficacy.]
[J01FA03, midecamycin, The serum concentration of Quinidine can be increased when it is combined with Midecamycin.]
[S01FA04, cyclopentolate, The risk or severity of adverse effects can be increased when Quinidine is combined with Cyclopentolate.]
[J05AF07, tenofovir disoproxil, Tenofovir disoproxil may decrease the excretion rate of Quinidine which could result in a higher serum level.]
[L01AA01, cyclophosphamide, The metabolism of Quinidine can be increased when combined with Cyclophosphamide.]
[N06AX07, minaprine, The metabolism of Minaprine can be decreased when combined with Quinidine.]
[S01XA18, cyclosporine, The serum concentration of Quinidine can be increased when it is combined with Cyclosporine.]
[N06AG02, moclobemide, The metabolism of Moclobemide can be decreased when combined with Quinidine.]
[N06BA07, modafinil, The metabolism of Quinidine can be increased when combined with Modafinil.]
[R06AX02, cyproheptadine, Cyproheptadine may increase the central nervous system depressant (CNS depressant) activities of Quinidine.]
[C09AA13, moexipril, The risk or severity of QTc prolongation can be increased when Moexipril is combined with Quinidine.]
[C10AA07, rosuvastatin, The metabolism of Quinidine can be decreased when combined with Rosuvastatin.]
[M02AA02, mofebutazone, Mofebutazone may decrease the excretion rate of Quinidine which could result in a higher serum level.]
[M01AX22, morniflumate, Morniflumate may decrease the excretion rate of Quinidine which could result in a higher serum level.]
[C03XA02, conivaptan, The metabolism of Quinidine can be decreased when combined with Conivaptan.]
[C02AC05, moxonidine, The therapeutic efficacy of Moxonidine can be decreased when used in combination with Quinidine.]
[L01BC01, cytarabine, The risk or severity of adverse effects can be increased when Quinidine is combined with Cytarabine.]
[J05AF10, entecavir, The metabolism of Entecavir can be decreased when combined with Quinidine.]
[G04BE09, vardenafil, The metabolism of Vardenafil can be decreased when combined with Quinidine.]
[M01AH05, etoricoxib, The metabolism of Quinidine can be decreased when combined with Etoricoxib.]
[L01AX04, dacarbazine, The metabolism of Dacarbazine can be decreased when combined with Quinidine.]
[L01DA01, dactinomycin, The serum concentration of Dactinomycin can be increased when it is combined with Quinidine.]
[G03XA01, danazol, The metabolism of Quinidine can be decreased when combined with Danazol.]
[M03CA01, dantrolene, Dantrolene may increase the central nervous system depressant (CNS depressant) activities of Quinidine.]
[J04BA02, dapsone, The risk or severity of adverse effects can be increased when Quinidine is combined with Dapsone.]
[L01DB02, daunorubicin, The metabolism of Quinidine can be decreased when combined with Daunorubicin.]
[N06BX04, deanol, Deanol may increase the central nervous system depressant (CNS depressant) activities of Quinidine.]
[C02CC04, debrisoquin, The metabolism of Debrisoquine can be decreased when combined with Quinidine.]
[A04AD11, nabilone, The risk or severity of Tachycardia and drowsiness can be increased when Quinidine is combined with Nabilone.]
[M01AX01, nabumetone, The metabolism of Nabumetone can be decreased when combined with Quinidine.]
[N07BB05, nalmefene, Nalmefene may decrease the excretion rate of Quinidine which could result in a higher serum level.]
[J01AA01, demeclocycline, The risk or severity of neuromuscular blockade can be increased when Demeclocycline is combined with Quinidine.]
[N05BA16, nordazepam, Nordazepam may increase the central nervous system depressant (CNS depressant) activities of Quinidine.]
[C07AB12, nebivolol, Quinidine may increase the arrhythmogenic activities of Nebivolol.]
[S01GX04, nedocromil, Nedocromil may decrease the excretion rate of Quinidine which could result in a higher serum level.]
[N06AX06, nefazodone, Quinidine may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Nefazodone.]
[N05CM16, niaprazine, Niaprazine may increase the central nervous system depressant (CNS depressant) activities of Quinidine.]
[C01DX16, nicorandil, Quinidine may increase the arrhythmogenic activities of Nicorandil.]
[L02BB02, nilutamide, Nilutamide may decrease the excretion rate of Quinidine which could result in a higher serum level.]
[N03AG06, tiagabine, Tiagabine may increase the central nervous system depressant (CNS depressant) activities of Quinidine.]
[C01CA23, theodrenaline, The serum concentration of Theodrenaline can be increased when it is combined with Quinidine.]
[M03AC11, cisatracurium, Quinidine may increase the neuromuscular blocking activities of Cisatracurium.]
[C01CA05, norfenefrine, The therapeutic efficacy of Norfenefrine can be decreased when used in combination with Quinidine.]
[R05DA06, normethadone, The risk or severity of adverse effects can be increased when Quinidine is combined with Normethadone.]
[B01AX05, fondaparinux, The therapeutic efficacy of Fondaparinux can be increased when used in combination with Quinidine.]
[N06AB10, escitalopram, The metabolism of Escitalopram can be decreased when combined with Quinidine.]
[G04BD08, solifenacin, The metabolism of Solifenacin can be decreased when combined with Quinidine.]
[A07EC03, olsalazine, Olsalazine may decrease the excretion rate of Quinidine which could result in a higher serum level.]
[N06AA01, desipramine, The metabolism of Quinidine can be decreased when combined with Desipramine.]
[C01AA07, deslanoside, The serum concentration of Deslanoside can be increased when it is combined with Quinidine.]
[H01BA02, desmopressin, Desmopressin may decrease the excretion rate of Quinidine which could result in a higher serum level.]
[V04CH02, indigo carmine, Indigotindisulfonic acid may decrease the excretion rate of Quinidine which could result in a higher serum level.]
[J01DH03, ertapenem, Ertapenem may decrease the excretion rate of Quinidine which could result in a higher serum level.]
[C09XA02, aliskiren, Quinidine may decrease the antihypertensive activities of Aliskiren.]
[L01XA03, oxaliplatin, The risk or severity of QTc prolongation can be increased when Oxaliplatin is combined with Quinidine.]
[M01AE12, oxaprozin, Oxaprozin may decrease the excretion rate of Quinidine which could result in a higher serum level.]
[N03AF02, oxcarbazepine, The metabolism of Quinidine can be increased when combined with Oxcarbazepine.]
[S03BA01, dexamethasone, The metabolism of Quinidine can be increased when combined with Dexamethasone.]
[N06BX07, oxiracetam, Oxiracetam may increase the central nervous system depressant (CNS depressant) activities of Quinidine.]
[N04AA08, dexetimide, The risk or severity of adverse effects can be increased when Quinidine is combined with Dexetimide.]
[G04BD04, oxybutynin, The metabolism of Quinidine can be decreased when combined with Oxybutynin.]
[A08AA04, dexfenfluramine, The metabolism of Dexfenfluramine can be decreased when combined with Quinidine.]
[A03AA01, oxyphencyclimine, The risk or severity of adverse effects can be increased when Oxyphencyclimine is combined with Quinidine.]
[L04AB04, adalimumab, The metabolism of Quinidine can be increased when combined with Adalimumab.]
[L01EB01, gefitinib, The metabolism of Gefitinib can be decreased when combined with Quinidine.]
[N06BA02, dextroamphetamine, The therapeutic efficacy of Quinidine can be decreased when used in combination with Amphetamine.]
[N03AC01, paramethadione, Paramethadione may increase the central nervous system depressant (CNS depressant) activities of Quinidine.]
[N02AC01, dextromoramide, The risk or severity of adverse effects can be increased when Quinidine is combined with Dextromoramide.]
[N06AB05, paroxetine, The metabolism of Paroxetine can be decreased when combined with Quinidine.]
[B01AC04, clopidogrel, The metabolism of Clopidogrel can be decreased when combined with Quinidine.]
[N07BC06, heroin, The risk or severity of adverse effects can be increased when Quinidine is combined with Diamorphine.]
[C01DA05, pentaerythritol tetranitrate, Pentaerythritol tetranitrate may decrease the excretion rate of Quinidine which could result in a higher serum level.]
[C04AD01, pentifylline, The serum concentration of Pentifylline can be increased when it is combined with Quinidine.]
[P03AC04, permethrin, Permethrin may decrease the excretion rate of Quinidine which could result in a higher serum level.]
[N05BA01, diazepam, The metabolism of Quinidine can be decreased when combined with Diazepam.]
[N03AX07, phenacemide, Phenacemide may increase the central nervous system depressant (CNS depressant) activities of Quinidine.]
[V03AH01, diazoxide, Quinidine may decrease the antihypertensive activities of Diazoxide.]
[R02AA19, phenol, The risk or severity of methemoglobinemia can be increased when Quinidine is combined with Phenol.]
[N03AD02, phensuximide, Phensuximide may increase the central nervous system depressant (CNS depressant) activities of Quinidine.]
[N06AA08, dibenzepin, Dibenzepin may increase the central nervous system depressant (CNS depressant) activities of Quinidine.]
[S02DA04, dibucaine, The risk or severity of methemoglobinemia can be increased when Quinidine is combined with Cinchocaine.]
[R05DA08, pholcodine, Pholcodine may decrease the excretion rate of Quinidine which could result in a higher serum level.]
[S01EC02, dichlorphenamide, The excretion of Quinidine can be decreased when combined with Diclofenamide.]
[S01BC03, diclofenac, The metabolism of Diclofenac can be decreased when combined with Quinidine.]
[J01CF01, dicloxacillin, The metabolism of Quinidine can be increased when combined with Dicloxacillin.]
[J05AD01, foscarnet, Foscarnet may decrease the excretion rate of Quinidine which could result in a higher serum level.]
[A03AA07, dicyclomine, Dicyclomine may decrease the excretion rate of Quinidine which could result in a higher serum level.]
[J05AF02, didanosine, Didanosine may decrease the excretion rate of Quinidine which could result in a higher serum level.]
[C02DG01, pinacidil, Quinidine may decrease the antihypertensive activities of Pinacidil.]
[A03AX04, pinaverium, Quinidine may increase the arrhythmogenic activities of Pinaverium.]
[A10BG03, pioglitazone, The metabolism of Pioglitazone can be increased when combined with Quinidine.]
[N05AD05, pipamperone, Pipamperone may increase the central nervous system depressant (CNS depressant) activities of Quinidine.]
[A03AB14, pipenzolate, The risk or severity of adverse effects can be increased when Quinidine is combined with Pipenzolate.]
[L01DC04, ixabepilone, The serum concentration of Quinidine can be increased when it is combined with Ixabepilone.]
[L01EB02, erlotinib, The metabolism of Erlotinib can be decreased when combined with Quinidine.]
[R03CC07, pirbuterol, The therapeutic efficacy of Pirbuterol can be decreased when used in combination with Quinidine.]
[C03CA03, piretanide, Piretanide may increase the excretion rate of Quinidine which could result in a lower serum level and potentially a reduction in efficacy.]
[P02CB02, diethylcarbamazine, The therapeutic efficacy of Quinidine can be decreased when used in combination with Diethylcarbamazine.]
[A08AA03, diethylpropion, The therapeutic efficacy of Quinidine can be decreased when used in combination with Diethylpropion.]
[L02AA01, diethylstilbestrol, The metabolism of Quinidine can be decreased when combined with Diethylstilbestrol.]
[C08CA03, isradipine, Isradipine may increase the arrhythmogenic activities of Quinidine.]
[D07XC04, diflucortolone, The metabolism of Quinidine can be increased when combined with Difluocortolone.]
[A03AB11, poldine, The risk or severity of adverse effects can be increased when Quinidine is combined with Poldine.]
[N02BA11, diflunisal, Diflunisal may decrease the excretion rate of Quinidine which could result in a higher serum level.]
[C01AA04, digitoxin, The serum concentration of Digitoxin can be increased when it is combined with Quinidine.]
[C01AA05, digoxin, The serum concentration of Digoxin can be increased when it is combined with Quinidine.]
[C02DB01, dihydralazine, The metabolism of Dihydralazine can be decreased when combined with Quinidine.]
[C10AX09, ezetimibe, Quinidine may decrease the excretion rate of Ezetimibe which could result in a higher serum level.]
[C04AE04, dihydroergocristine, The metabolism of Quinidine can be decreased when combined with Dihydroergocristine.]
[N02CA01, dihydroergotamine, Dihydroergotamine may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Quinidine.]
[N02AA03, hydromorphone, The risk or severity of adverse effects can be increased when Quinidine is combined with Hydromorphone.]
[L04AX04, lenalidomide, Lenalidomide may decrease the excretion rate of Quinidine which could result in a higher serum level.]
[J05AE08, atazanavir, The metabolism of Quinidine can be decreased when combined with Atazanavir.]
[B01AC21, treprostinil, The risk or severity of QTc prolongation can be increased when Treprostinil is combined with Quinidine.]
[H03BC01, potassium perchlorate, Potassium perchlorate may decrease the excretion rate of Quinidine which could result in a higher serum level.]
[V03AB04, pralidoxime, Pralidoxime may decrease the excretion rate of Quinidine which could result in a higher serum level.]
[D04AB07, pramoxine, The risk or severity of methemoglobinemia can be increased when Quinidine is combined with Pramocaine.]
[C08DB01, diltiazem, Diltiazem may increase the arrhythmogenic activities of Quinidine.]
[R06AA11, dimenhydrinate, The risk or severity of QTc prolongation can be increased when Dimenhydrinate is combined with Quinidine.]
[V03AB09, dimercaprol, Dimercaprol may decrease the excretion rate of Quinidine which could result in a higher serum level.]
[M03BX03, pridinol, Pridinol may increase the central nervous system depressant (CNS depressant) activities of Quinidine.]
[R06AB03, dimethindene, The risk or severity of adverse effects can be increased when Quinidine is combined with Dimetindene.]
[R03CC08, procaterol, The therapeutic efficacy of Procaterol can be decreased when used in combination with Quinidine.]
[M02AX03, dimethyl sulfoxide, The metabolism of Quinidine can be decreased when combined with Dimethyl sulfoxide.]
[N03AG05, progabide, Progabide may increase the central nervous system depressant (CNS depressant) activities of Quinidine.]
[N06BC02, propentofylline, The serum concentration of Propentofylline can be increased when it is combined with Quinidine.]
[N02BB04, propyphenazone, Propyphenazone may decrease the excretion rate of Quinidine which could result in a higher serum level.]
[M01AB14, proglumetacin, Proglumetacin may decrease the excretion rate of Quinidine which could result in a higher serum level.]
[G02AD02, dinoprostone, The excretion of Dinoprostone can be decreased when combined with Quinidine.]
[C05CA03, diosmin, The serum concentration of Quinidine can be increased when it is combined with Diosmin.]
[S01HA04, proparacaine, The risk or severity of methemoglobinemia can be increased when Quinidine is combined with Proparacaine.]
[R03DA03, proxyphylline, The serum concentration of Proxyphylline can be increased when it is combined with Quinidine.]
[R06AA02, diphenhydramine, The risk or severity of methemoglobinemia can be increased when Quinidine is combined with Diphenhydramine.]
[A07DA01, diphenoxylate, The risk or severity of adverse effects can be increased when Quinidine is combined with Diphenoxylate.]
[N05CD10, quazepam, Quazepam may increase the central nervous system depressant (CNS depressant) activities of Quinidine.]
[C09AA06, quinapril, The excretion of Quinapril can be decreased when combined with Quinidine.]
[B01AC07, dipyridamole, The therapeutic efficacy of Dipyridamole can be increased when used in combination with Quinidine.]
[N06BA11, dexmethylphenidate, Dexmethylphenidate may increase the central nervous system depressant (CNS depressant) activities of Quinidine.]
[B01AD10, drotrecogin alfa, The therapeutic efficacy of Drotrecogin alfa can be increased when used in combination with Quinidine.]
[N06AA23, quinupramine, Quinupramine may increase the central nervous system depressant (CNS depressant) activities of Quinidine.]
[A03FA02, cisapride, The metabolism of Quinidine can be decreased when combined with Cisapride.]
[C09AA05, ramipril, Quinidine may decrease the antihypertensive activities of Ramipril.]
[S01XA23, sirolimus, The serum concentration of Quinidine can be increased when it is combined with Sirolimus.]
[N05AL04, remoxipride, The metabolism of Remoxipride can be decreased when combined with Quinidine.]
[R03CC14, reproterol, The therapeutic efficacy of Reproterol can be decreased when used in combination with Quinidine.]
[S01AX06, resorcinol, Resorcinol may decrease the excretion rate of Quinidine which could result in a higher serum level.]
[C01BA03, disopyramide, Disopyramide may increase the arrhythmogenic activities of Quinidine.]
[N07AA03, distigmine, The therapeutic efficacy of Quinidine can be decreased when used in combination with Distigmine.]
[P03AA04, disulfiram, Quinidine may decrease the excretion rate of Disulfiram which could result in a higher serum level.]
[S02AA12, rifamycin SV, The serum concentration of Quinidine can be increased when it is combined with Rifamycin.]
[J04AB05, rifapentine, The metabolism of Quinidine can be increased when combined with Rifapentine.]
[D06AX11, rifaximin, The serum concentration of Rifaximin can be increased when it is combined with Quinidine.]
[N07XX02, riluzole, The metabolism of Riluzole can be decreased when combined with Quinidine.]
[N05AX08, risperidone, Risperidone may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Quinidine.]
[R06AE09, levocetirizine, Levocetirizine may decrease the excretion rate of Quinidine which could result in a higher serum level.]
[N01BB09, ropivacaine, The risk or severity of methemoglobinemia can be increased when Quinidine is combined with Ropivacaine.]
[J01MB01, rosoxacin, The risk or severity of QTc prolongation can be increased when Rosoxacin is combined with Quinidine.]
[L01EX01, sunitinib, The metabolism of Sunitinib can be decreased when combined with Quinidine.]
[A04AD12, aprepitant, The metabolism of Quinidine can be decreased when combined with Aprepitant.]
[C03XA01, tolvaptan, The serum concentration of Tolvaptan can be increased when it is combined with Quinidine.]
[L01XG01, bortezomib, The serum concentration of Bortezomib can be increased when it is combined with Quinidine.]
[J05AE07, fosamprenavir, The metabolism of Quinidine can be decreased when combined with Fosamprenavir.]
[G04BE08, tadalafil, Tadalafil may decrease the excretion rate of Quinidine which could result in a higher serum level.]
[S01BC05, ketorolac, Ketorolac may decrease the excretion rate of Quinidine which could result in a higher serum level.]
[C02KX02, ambrisentan, The serum concentration of Ambrisentan can be increased when it is combined with Quinidine.]
[C01EB18, ranolazine, The serum concentration of Ranolazine can be increased when it is combined with Quinidine.]
[N02BA06, salsalate, Salsalate may decrease the excretion rate of Quinidine which could result in a higher serum level.]
[R03AC12, salmeterol, The metabolism of Quinidine can be decreased when combined with Salmeterol.]
[H05BA01, salmon calcitonin, Salmon calcitonin may decrease the excretion rate of Quinidine which could result in a higher serum level.]
[C01CA07, dobutamine, Dobutamine may decrease the excretion rate of Quinidine which could result in a higher serum level.]
[A03FA03, domperidone, The therapeutic efficacy of Domperidone can be decreased when used in combination with Quinidine.]
[C01CA04, dopamine, Dopamine may decrease the excretion rate of Quinidine which could result in a higher serum level.]
[N06AA16, dothiepin, The metabolism of Dosulepin can be decreased when combined with Quinidine.]
[R07AB01, doxapram, The risk or severity of hypertension can be increased when Doxapram is combined with Quinidine.]
[N06AA12, doxepin, Quinidine may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Doxepin.]
[A06AB06, sennosides, USP, The therapeutic efficacy of Sennosides can be decreased when used in combination with Quinidine.]
[L01DB01, doxorubicin, The serum concentration of Doxorubicin can be increased when it is combined with Quinidine.]
[J01AA02, doxycycline, Doxycycline may decrease the excretion rate of Quinidine which could result in a higher serum level.]
[R06AA09, doxylamine, Doxylamine may increase the central nervous system depressant (CNS depressant) activities of Quinidine.]
[N06AB06, sertraline, The metabolism of Sertraline can be decreased when combined with Quinidine.]
[N01AB08, sevoflurane, Sevoflurane may increase the central nervous system depressant (CNS depressant) activities of Quinidine.]
[N05AD08, droperidol, Droperidol may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Quinidine.]
[A08AA10, sibutramine, Sibutramine may decrease the excretion rate of Quinidine which could result in a higher serum level.]
[C10AA01, simvastatin, The serum concentration of Quinidine can be increased when it is combined with Simvastatin.]
[B05XA02, sodium bicarbonate, Sodium bicarbonate may decrease the excretion rate of Quinidine which could result in a higher serum level.]
[V03AG05, sodium phosphate, The therapeutic efficacy of Sodium phosphate, monobasic can be decreased when used in combination with Quinidine.]
[A12CA02, sodium sulfate, Sodium sulfate may decrease the excretion rate of Quinidine which could result in a higher serum level.]
[C09AA11, spirapril, Quinidine may decrease the antihypertensive activities of Spirapril.]
[R03DA01, dyphylline, The serum concentration of Dyphylline can be increased when it is combined with Quinidine.]
[N05AL02, sultopride, The risk or severity of QTc prolongation can be increased when Sultopride is combined with Quinidine.]
[N02CC01, sumatriptan, Sumatriptan may decrease the excretion rate of Quinidine which could result in a higher serum level.]
[V04CX07, edrophonium, Edrophonium may decrease the excretion rate of Quinidine which could result in a higher serum level.]
[C07AB13, talinolol, Quinidine may increase the arrhythmogenic activities of Talinolol.]
[H01AA01, corticotropin, The metabolism of Quinidine can be increased when combined with Corticotropin.]
[J01CG02, tazobactam, The excretion of Tazobactam can be decreased when combined with Quinidine.]
[J01MA05, temafloxacin, The risk or severity of QTc prolongation can be increased when Quinidine is combined with Temafloxacin.]
[L01AX03, temozolomide, Temozolomide may decrease the excretion rate of Quinidine which could result in a higher serum level.]
[M01AC02, tenoxicam, Tenoxicam may decrease the excretion rate of Quinidine which could result in a higher serum level.]
[G04CA03, terazosin, Quinidine may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Terazosin.]
[D01BA02, terbinafine, The metabolism of Quinidine can be increased when combined with Terbinafine.]
[G04BD05, terodiline, Quinidine may increase the arrhythmogenic activities of Terodiline.]
[C07AA16, tertatolol, Quinidine may increase the arrhythmogenic activities of Tertatolol.]
[S01GA02, tetrahydrozoline, The therapeutic efficacy of Tetryzoline can be decreased when used in combination with Quinidine.]
[M03BX07, tetrazepam, Tetrazepam may increase the central nervous system depressant (CNS depressant) activities of Quinidine.]
[M03BX05, thiocolchicoside, Thiocolchicoside may increase the central nervous system depressant (CNS depressant) activities of Quinidine.]
[N05AB05, thiopropazate, Thiopropazate may increase the central nervous system depressant (CNS depressant) activities of Quinidine.]
[G04BD01, emepronium, Emepronium may increase the central nervous system depressant (CNS depressant) activities of Quinidine.]
[N06AX14, tianeptine, The metabolism of Tianeptine can be decreased when combined with Quinidine.]
[C09AA02, enalapril, Quinidine may decrease the antihypertensive activities of Enalapril.]
[N05BA23, tofisopam, Tofisopam may increase the central nervous system depressant (CNS depressant) activities of Quinidine.]
[M01AG02, tolfenamic acid, Tolfenamic acid may decrease the excretion rate of Quinidine which could result in a higher serum level.]
[N06AG03, toloxatone, Toloxatone may decrease the excretion rate of Quinidine which could result in a higher serum level.]
[N06BA09, atomoxetine, The metabolism of Atomoxetine can be decreased when combined with Quinidine.]
[N03AX11, topiramate, The risk or severity of hyperthermia and oligohydrosis can be increased when Quinidine is combined with Topiramate.]
[L02BA02, toremifene, The serum concentration of Quinidine can be increased when it is combined with Toremifene.]
[C03CA04, torsemide, The metabolism of Torasemide can be decreased when combined with Quinidine.]
[J01AA12, tigecycline, The risk or severity of neuromuscular blockade can be increased when Tigecycline is combined with Quinidine.]
[R01AA09, tramazoline, The risk or severity of hypertension can be increased when Quinidine is combined with Tramazoline.]
[C09AA10, trandolapril, Quinidine may decrease the antihypertensive activities of Trandolapril.]
[N05CD11, triazulenone, Loprazolam may increase the central nervous system depressant (CNS depressant) activities of Quinidine.]
[N05CC01, chloral hydrate, Chloral hydrate may decrease the excretion rate of Quinidine which could result in a higher serum level.]
[N05CM07, triclofos, Triclofos may increase the central nervous system depressant (CNS depressant) activities of Quinidine.]
[A03AB08, tridihexethyl, The risk or severity of adverse effects can be increased when Tridihexethyl is combined with Quinidine.]
[B01AC18, triflusal, The therapeutic efficacy of Triflusal can be increased when used in combination with Quinidine.]
[R06AA10, trimethobenzamide, Trimethobenzamide may increase the central nervous system depressant (CNS depressant) activities of Quinidine.]
[L02AE04, triptorelin, The risk or severity of QTc prolongation can be increased when Triptorelin is combined with Quinidine.]
[N04AA12, tropatepine, The risk or severity of adverse effects can be increased when Quinidine is combined with Tropatepine.]
[C05CA04, troxerutin, The therapeutic efficacy of Troxerutin can be increased when used in combination with Quinidine.]
[R03CC11, tulobuterol, The therapeutic efficacy of Tulobuterol can be decreased when used in combination with Quinidine.]
[N01AB04, enflurane, Enflurane may increase the central nervous system depressant (CNS depressant) activities of Quinidine.]
[C02CA06, urapidil, Quinidine may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Urapidil.]
[J01MA04, enoxacin, The risk or severity of QTc prolongation can be increased when Enoxacin is combined with Quinidine.]
[N05AL06, veralipride, Veralipride may increase the central nervous system depressant (CNS depressant) activities of Quinidine.]
[L01CA04, vinorelbine, The metabolism of Vinorelbine can be decreased when combined with Quinidine.]
[S01FB02, ephedrine, The therapeutic efficacy of Ephedrine can be decreased when used in combination with Quinidine.]
[S01GX10, epinastine, The metabolism of Epinastine can be decreased when combined with Quinidine.]
[N06AX16, venlafaxine, The metabolism of Venlafaxine can be decreased when combined with Quinidine.]
[C01CX07, xamoterol, The therapeutic efficacy of Xamoterol can be decreased when used in combination with Quinidine.]
[S01GA03, xylometazoline, Quinidine may increase the arrhythmogenic activities of Xylometazoline.]
[C08CA12, mepirodipine, Quinidine may increase the arrhythmogenic activities of Barnidipine.]
[S01EA01, epinephrine, The metabolism of Quinidine can be decreased when combined with Epinephrine.]
[C09AA15, zofenopril, Quinidine may decrease the antihypertensive activities of Zofenopril.]
[N05CF02, zolpidem, The metabolism of Zolpidem can be decreased when combined with Quinidine.]
[M01AB04, zomepirac, Zomepirac may decrease the excretion rate of Quinidine which could result in a higher serum level.]
[N03AX15, zonisamide, Quinidine may increase the arrhythmogenic activities of Zonisamide.]
[N05CF01, zopiclone, The metabolism of Zopiclone can be decreased when combined with Quinidine.]
[N05AX11, zotepine, The metabolism of Zotepine can be decreased when combined with Quinidine.]
[B01AD03, anistreplase, The therapeutic efficacy of Anistreplase can be increased when used in combination with Quinidine.]
[L01XA02, carboplatin, Carboplatin may decrease the excretion rate of Quinidine which could result in a higher serum level.]
[C02AC02, guanfacine, Guanfacine may decrease the excretion rate of Quinidine which could result in a higher serum level.]
[C01BG01, moricizine, Moricizine may increase the arrhythmogenic activities of Quinidine.]
[G02AB03, ergonovine, The therapeutic efficacy of Ergometrine can be decreased when used in combination with Quinidine.]
[C04AE01, ergoloid mesylates, USP, Ergoloid mesylate may increase the central nervous system depressant (CNS depressant) activities of Quinidine.]
[N02CA02, ergotamine, Ergotamine may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Quinidine.]
[N03AG01, valproic acid, The metabolism of Quinidine can be decreased when combined with Valproic acid.]
[L03AX05, pidotimod, Pidotimod may decrease the excretion rate of Quinidine which could result in a higher serum level.]
[S01AA17, erythromycin, The risk or severity of QTc prolongation can be increased when Erythromycin is combined with Quinidine.]
[N05CD04, estazolam, Estazolam may decrease the excretion rate of Quinidine which could result in a higher serum level.]
[A02BC02, pantoprazole, Pantoprazole may decrease the excretion rate of Quinidine which could result in a higher serum level.]
[H05BX01, cinacalcet, The metabolism of Cinacalcet can be decreased when combined with Quinidine.]
[G03CA03, estradiol, The metabolism of Quinidine can be decreased when combined with Estradiol.]
[G03CA57, estrogens, conjugated (USP), The metabolism of Conjugated estrogens can be decreased when combined with Quinidine.]
[J04AK02, ethambutol, The metabolism of Quinidine can be decreased when combined with Ethambutol.]
[R03BA09, fluticasone furoate, The metabolism of Quinidine can be increased when combined with Fluticasone furoate.]
[R03BA05, fluticasone, The metabolism of Quinidine can be increased when combined with Fluticasone.]
[C10AA04, fluvastatin, The metabolism of Fluvastatin can be decreased when combined with Quinidine.]
[V08CA03, gadodiamide, Gadodiamide may decrease the excretion rate of Quinidine which could result in a higher serum level.]
[C01CA15, gepefrine, The therapeutic efficacy of Quinidine can be decreased when used in combination with Gepefrine.]
[N05CM08, ethchlorvynol, Ethchlorvynol may increase the central nervous system depressant (CNS depressant) activities of Quinidine.]
[L02AA03, ethinyl estradiol, The metabolism of Ethinylestradiol can be decreased when combined with Quinidine.]
[C01BD05, ibutilide, Ibutilide may increase the arrhythmogenic activities of Quinidine.]
[N04AA05, profenamine, The risk or severity of adverse effects can be increased when Profenamine is combined with Quinidine.]
[N03AD01, ethosuximide, Ethosuximide may increase the arrhythmogenic activities of Quinidine.]
[N03AB01, ethotoin, Ethotoin may increase the central nervous system depressant (CNS depressant) activities of Quinidine.]
[N01BX01, ethyl chloride, The risk or severity of methemoglobinemia can be increased when Quinidine is combined with Ethyl chloride.]
[M01AC06, meloxicam, The risk or severity of methemoglobinemia can be increased when Quinidine is combined with Meloxicam.]
[S01XA06, ethylmorphine, The risk or severity of adverse effects can be increased when Quinidine is combined with Ethylmorphine.]
[C01CA01, etilefrine, The therapeutic efficacy of Etilefrine can be decreased when used in combination with Quinidine.]
[N01BB07, etidocaine, The risk or severity of methemoglobinemia can be increased when Quinidine is combined with Etidocaine.]
[N01AX07, etomidate, Etomidate may decrease the excretion rate of Quinidine which could result in a higher serum level.]
[L01CB01, etoposide, The serum concentration of Etoposide can be increased when it is combined with Quinidine.]
[N05AE03, sertindole, The metabolism of Sertindole can be decreased when combined with Quinidine.]
[C01BA05, ajmaline, Quinidine may increase the arrhythmogenic activities of Ajmaline.]
[L04AD02, tacrolimus, The serum concentration of Tacrolimus can be increased when it is combined with Quinidine.]
[A02BA04, nizatidine, The therapeutic efficacy of Quinidine can be decreased when used in combination with Nizatidine.]
[J01MA08, fleroxacin, The risk or severity of QTc prolongation can be increased when Fleroxacin is combined with Quinidine.]
[R06AX11, astemizole, The metabolism of Astemizole can be decreased when combined with Quinidine.]
[R06AX12, terfenadine, The metabolism of Quinidine can be decreased when combined with Terfenadine.]
[P01AX07, trimetrexate, Trimetrexate may decrease the excretion rate of Quinidine which could result in a higher serum level.]
[N06AX12, bupropion, The risk or severity of seizure can be increased when Bupropion is combined with Quinidine.]
[N06AB08, fluvoxamine, The metabolism of Quinidine can be decreased when combined with Fluvoxamine.]
[C01BB03, tocainide, Quinidine may increase the arrhythmogenic activities of Tocainide.]
[C01BC08, encainide, Quinidine may increase the arrhythmogenic activities of Encainide.]
[L02AE02, leuprolide, The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Quinidine.]
[C10AA03, pravastatin, Quinidine may decrease the excretion rate of Pravastatin which could result in a higher serum level.]
[M01CB01, gold sodium thiomalate, Sodium aurothiomalate may decrease the excretion rate of Quinidine which could result in a higher serum level.]
[B05AA05, dextran, The therapeutic efficacy of Dextran can be increased when used in combination with Quinidine.]
[V03AF02, dexrazoxane, Dexrazoxane may decrease the excretion rate of Quinidine which could result in a higher serum level.]
[A02BA03, famotidine, The excretion of Famotidine can be decreased when combined with Quinidine.]
[A16AA01, levocarnitine, Levocarnitine may decrease the excretion rate of Quinidine which could result in a higher serum level.]
[P02CA03, albendazole, The metabolism of Albendazole can be decreased when combined with Quinidine.]
[C08CA02, felodipine, Quinidine may increase the arrhythmogenic activities of Felodipine.]
[C08EA01, fendiline, Quinidine may increase the arrhythmogenic activities of Fendiline.]
[N03AX26, fenfluramine, The metabolism of Fenfluramine can be decreased when combined with Quinidine.]
[M01AE04, fenoprofen, Fenoprofen may decrease the excretion rate of Quinidine which could result in a higher serum level.]
[R03CC04, fenoterol, The therapeutic efficacy of Fenoterol can be decreased when used in combination with Quinidine.]
[N02AB03, fentanyl, The metabolism of Fentanyl can be decreased when combined with Quinidine.]
[R03CC02, albuterol, Salbutamol may decrease the excretion rate of Quinidine which could result in a higher serum level.]
[B01AD05, plasmin, The therapeutic efficacy of Fibrinolysin can be increased when used in combination with Quinidine.]
[L01BB06, clofarabine, The serum concentration of Clofarabine can be increased when it is combined with Quinidine.]
[N07AX03, cevimeline, The metabolism of Cevimeline can be decreased when combined with Quinidine.]
[G04BD02, flavoxate, Flavoxate may decrease the excretion rate of Quinidine which could result in a higher serum level.]
[C01BC04, flecainide, Quinidine may increase the arrhythmogenic activities of Flecainide.]
[N02BG04, floctafenine, Floctafenine may decrease the excretion rate of Quinidine which could result in a higher serum level.]
[J01CF05, floxacillin, The metabolism of Quinidine can be increased when combined with Flucloxacillin.]
[J02AC01, fluconazole, The serum concentration of Quinidine can be increased when it is combined with Fluconazole.]
[J02AX01, flucytosine, Flucytosine may decrease the excretion rate of Quinidine which could result in a higher serum level.]
[V03AB25, flumazenil, Flumazenil may decrease the excretion rate of Quinidine which could result in a higher serum level.]
[N07CA03, flunarizine, Quinidine may increase the arrhythmogenic activities of Flunarizine.]
[N05CD03, flunitrazepam, Flunitrazepam may increase the central nervous system depressant (CNS depressant) activities of Quinidine.]
[D07AC08, fluocinonide, The metabolism of Quinidine can be increased when combined with Fluocinonide.]
[N06AA14, melitracen, Melitracen may increase the central nervous system depressant (CNS depressant) activities of Quinidine.]
[H02AB03, fluocortolone, The metabolism of Quinidine can be increased when combined with Fluocortolone.]
[V03AZ01, ethanol, The metabolism of Quinidine can be increased when combined with Ethanol.]
[L01BC09, floxuridine, Floxuridine may decrease the excretion rate of Quinidine which could result in a higher serum level.]
[L01BC02, fluorouracil, The metabolism of Fluorouracil can be decreased when combined with Quinidine.]
[N06AB03, fluoxetine, The risk or severity of QTc prolongation can be increased when Fluoxetine is combined with Quinidine.]
[N05AF01, flupenthixol, The risk or severity of QTc prolongation can be increased when Quinidine is combined with Flupentixol.]
[N05AB02, fluphenazine, The risk or severity of QTc prolongation can be increased when Quinidine is combined with Fluphenazine.]
[N05CD01, flurazepam, Flurazepam may decrease the excretion rate of Quinidine which could result in a higher serum level.]
[S01BC04, flurbiprofen, Flurbiprofen may decrease the excretion rate of Quinidine which could result in a higher serum level.]
[N05AG01, fluspirilene, Quinidine may increase the arrhythmogenic activities of Fluspirilene.]
[L02BB01, flutamide, The metabolism of Flutamide can be decreased when combined with Quinidine.]
[V04CX02, folic acid, Folic acid may decrease the excretion rate of Quinidine which could result in a higher serum level.]
[S02AA17, fosfomycin, Fosfomycin may decrease the excretion rate of Quinidine which could result in a higher serum level.]
[S01AA07, framycetin, Framycetin may decrease the excretion rate of Quinidine which could result in a higher serum level.]
[L01BC03, tegafur, The metabolism of Tegafur can be decreased when combined with Quinidine.]
[N06BX17, adrafinil, The therapeutic efficacy of Adrafinil can be decreased when used in combination with Quinidine.]
[M03AA01, alcuronium, The therapeutic efficacy of Alcuronium can be increased when used in combination with Quinidine.]
[G01AX06, furazolidone, Furazolidone may increase the central nervous system depressant (CNS depressant) activities of Quinidine.]
[J05AE10, darunavir, The serum concentration of Quinidine can be increased when it is combined with Darunavir.]
[C03CA01, furosemide, Furosemide may decrease the excretion rate of Quinidine which could result in a higher serum level.]
[N05CF04, eszopiclone, The metabolism of Eszopiclone can be decreased when combined with Quinidine.]
[N05AL05, amisulpride, Amisulpride may increase the central nervous system depressant (CNS depressant) activities of Quinidine.]
[N06DA04, galantamine, The metabolism of Galantamine can be decreased when combined with Quinidine.]
[M03AC02, gallamine, The therapeutic efficacy of Gallamine can be increased when used in combination with Quinidine.]
[C08DA02, gallopamil, Quinidine may increase the arrhythmogenic activities of Gallopamil.]
[S01AD09, ganciclovir, Ganciclovir may decrease the excretion rate of Quinidine which could result in a higher serum level.]
[N03AA04, barbexaclone, The metabolism of Quinidine can be increased when combined with Barbexaclone.]
[N06AX08, bifemelane, Bifemelane may increase the central nervous system depressant (CNS depressant) activities of Quinidine.]
[C10AB04, gemfibrozil, Gemfibrozil may decrease the excretion rate of Quinidine which could result in a higher serum level.]
[J01XA03, telavancin, The risk or severity of QTc prolongation can be increased when Telavancin is combined with Quinidine.]
[L02BX02, degarelix, The risk or severity of QTc prolongation can be increased when Degarelix is combined with Quinidine.]
[L01EA02, dasatinib, The serum concentration of Dasatinib can be increased when it is combined with Quinidine.]
[N04BC06, cabergoline, The serum concentration of Cabergoline can be increased when it is combined with Quinidine.]
[C01CA21, cafedrine, The serum concentration of Cafedrine can be increased when it is combined with Quinidine.]
[J05AG04, etravirine, The metabolism of Quinidine can be increased when combined with Etravirine.]
[N03AD03, methsuximide, Quinidine may increase the arrhythmogenic activities of Methsuximide.]
[N01AH02, alfentanil, The risk or severity of adverse effects can be increased when Quinidine is combined with Alfentanil.]
[L01EH01, lapatinib, The serum concentration of Quinidine can be increased when it is combined with Lapatinib.]
[A10BB01, glyburide, The metabolism of Quinidine can be decreased when combined with Glyburide.]
[A10BB09, gliclazide, The metabolism of Gliclazide can be decreased when combined with Quinidine.]
[A10BB07, glipizide, Glipizide may decrease the excretion rate of Quinidine which could result in a higher serum level.]
[H04AA01, glucagon, Quinidine may increase the gastrointestinal motility reducing activities of Glucagon.]
[N05CM18, dexmedetomidine, Dexmedetomidine may decrease the excretion rate of Quinidine which could result in a higher serum level.]
[N05CE01, glutethimide, Glutethimide may increase the central nervous system depressant (CNS depressant) activities of Quinidine.]
[A06AX01, glycerin, The therapeutic efficacy of Glycerin can be decreased when used in combination with Quinidine.]
[C05AE01, nitroglycerin, Quinidine may decrease the antihypertensive activities of Nitroglycerin.]
[C01BD04, dofetilide, Dofetilide may increase the arrhythmogenic activities of Quinidine.]
[C02CA04, doxazosin, Doxazosin may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Quinidine.]
[L01EX02, sorafenib, The serum concentration of Quinidine can be increased when it is combined with Sorafenib.]
[C07AB09, esmolol, Esmolol may increase the arrhythmogenic activities of Quinidine.]
[M01CB04, aurothioglucose, Aurothioglucose may decrease the excretion rate of Quinidine which could result in a higher serum level.]
[S01LA03, pegaptanib, Pegaptanib may decrease the excretion rate of Quinidine which could result in a higher serum level.]
[B01AA12, fluindione, The therapeutic efficacy of Fluindione can be increased when used in combination with Quinidine.]
[C09AA09, fosinopril, Fosinopril may decrease the excretion rate of Quinidine which could result in a higher serum level.]
[D01BA01, griseofulvin, The metabolism of Quinidine can be increased when combined with Griseofulvin.]
[S01EX01, guanethidine, Guanethidine may decrease the excretion rate of Quinidine which could result in a higher serum level.]
[L02AE03, goserelin, The risk or severity of QTc prolongation can be increased when Goserelin is combined with Quinidine.]
[P01BX01, halofantrine, The risk or severity of QTc prolongation, ventricular arrhythmias, torsade de pointes, and convulsion can be increased when Quinidine is combined with Halofantrine.]
[N05AD01, haloperidol, The risk or severity of QTc prolongation can be increased when Quinidine is combined with Haloperidol.]
[N01AB01, halothane, Halothane may increase the central nervous system depressant (CNS depressant) activities of Quinidine.]
[L02AE05, histrelin, The risk or severity of QTc prolongation can be increased when Histrelin is combined with Quinidine.]
[N05AH04, quetiapine, Quinidine may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Quetiapine.]
[N06BX13, idebenone, Idebenone may decrease the excretion rate of Quinidine which could result in a higher serum level.]
[N02CX03, iprazochrome, Iprazochrome may increase the central nervous system depressant (CNS depressant) activities of Quinidine.]
[L01CE02, irinotecan, The metabolism of Irinotecan can be decreased when combined with Quinidine.]
[N05CA21, allobarbital, Allobarbital may increase the central nervous system depressant (CNS depressant) activities of Quinidine.]
[M04AA01, allopurinol, Allopurinol may decrease the excretion rate of Quinidine which could result in a higher serum level.]
[C09CA01, losartan, Losartan may increase the arrhythmogenic activities of Quinidine.]
[S01XA14, heparin, The therapeutic efficacy of Heparin can be increased when used in combination with Quinidine.]
[B05CB03, magnesium citrate, The therapeutic efficacy of Magnesium citrate can be decreased when used in combination with Quinidine.]
[A12CC03, magnesium gluconate, The risk or severity of neuromuscular blockade can be increased when Quinidine is combined with Magnesium gluconate.]
[G03DC01, allylestrenol, Allylestrenol may decrease the excretion rate of Quinidine which could result in a higher serum level.]
[A07EC02, mesalamine, Mesalazine may decrease the excretion rate of Quinidine which could result in a higher serum level.]
[C01CE02, milrinone, Milrinone may decrease the excretion rate of Quinidine which could result in a higher serum level.]
[A12CD02, sodium monofluorophosphate, The therapeutic efficacy of Sodium fluorophosphate can be decreased when used in combination with Quinidine.]
[N05CA16, hexobarbital, Hexobarbital may increase the central nervous system depressant (CNS depressant) activities of Quinidine.]
[R03CC05, hexoprenaline, The therapeutic efficacy of Hexoprenaline can be decreased when used in combination with Quinidine.]
[J05AG01, nevirapine, The metabolism of Quinidine can be decreased when combined with Nevirapine.]
[C08CA10, nilvadipine, Quinidine may increase the arrhythmogenic activities of Nilvadipine.]
[M02AA26, nimesulide, Quinidine may increase the arrhythmogenic activities of Nimesulide.]
[R06AE06, oxatomide, The risk or severity of QTc prolongation can be increased when Oxatomide is combined with Quinidine.]
[C09AA04, perindopril, Perindopril may decrease the excretion rate of Quinidine which could result in a higher serum level.]
[C02DB02, hydralazine, The metabolism of Quinidine can be decreased when combined with Hydralazine.]
[C03AA03, hydrochlorothiazide, Hydrochlorothiazide may decrease the excretion rate of Quinidine which could result in a higher serum level.]
[R05DA03, hydrocodone, The metabolism of Hydrocodone can be decreased when combined with Quinidine.]
[S02BA01, hydrocortisone, The metabolism of Quinidine can be increased when combined with Hydrocortisone.]
[D07AB02, hydrocortisone butyrate, The metabolism of Quinidine can be increased when combined with Hydrocortisone butyrate.]
[C03AA02, hydroflumethiazide, Hydroflumethiazide may increase the excretion rate of Quinidine which could result in a lower serum level and potentially a reduction in efficacy.]
[B05XA17, potassium acetate, Potassium acetate may decrease the excretion rate of Quinidine which could result in a higher serum level.]
[A12BA02, potassium citrate, Potassium citrate may increase the excretion rate of Quinidine which could result in a lower serum level and potentially a reduction in efficacy.]
[V03AB33, hydroxocobalamin, Hydroxocobalamin may decrease the excretion rate of Quinidine which could result in a higher serum level.]
[G04BD06, propiverine, Quinidine may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Propiverine.]
[P01BA02, hydroxychloroquine, The metabolism of Hydroxychloroquine can be decreased when combined with Quinidine.]
[N05AX07, prothipendyl, Prothipendyl may increase the central nervous system depressant (CNS depressant) activities of Quinidine.]
[B05AA07, hetastarch, Hydroxyethyl Starch may decrease the excretion rate of Quinidine which could result in a higher serum level.]
[N05BB01, hydroxyzine, The risk or severity of QTc prolongation can be increased when Quinidine is combined with Hydroxyzine.]
[J04AB04, rifabutin, The metabolism of Quinidine can be increased when combined with Rifabutin.]
[C02AC06, rilmenidine, The therapeutic efficacy of Rilmenidine can be decreased when used in combination with Quinidine.]
[R02AX02, ibuprofen, Ibuprofen may decrease the excretion rate of Quinidine which could result in a higher serum level.]
[B05XA08, sodium acetate, Sodium acetate may decrease the excretion rate of Quinidine which could result in a higher serum level.]
[B05CB02, sodium citrate, The therapeutic efficacy of Sodium citrate can be increased when used in combination with Quinidine.]
[L01DB06, idarubicin, The metabolism of Idarubicin can be decreased when combined with Quinidine.]
[A06AD21, sodium tartrate, The therapeutic efficacy of Sodium tartrate can be decreased when used in combination with Quinidine.]
[L01AA06, ifosfamide, The metabolism of Quinidine can be increased when combined with Ifosfamide.]
[N01AH03, sufentanil, The risk or severity of adverse effects can be increased when Quinidine is combined with Sufentanil.]
[N06AA02, imipramine, Imipramine may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Quinidine.]
[L01CD01, paclitaxel, The metabolism of Quinidine can be increased when combined with Paclitaxel.]
[H01BA04, terlipressin, The risk or severity of QTc prolongation can be increased when Terlipressin is combined with Quinidine.]
[R01AD07, tixocortol, Tixocortol may decrease the excretion rate of Quinidine which could result in a higher serum level.]
[M03BX02, tizanidine, The serum concentration of Tizanidine can be increased when it is combined with Quinidine.]
[L01CE01, topotecan, The serum concentration of Topotecan can be increased when it is combined with Quinidine.]
[C03BA11, indapamide, Indapamide may decrease the excretion rate of Quinidine which could result in a higher serum level.]
[S01BC01, indomethacin, Indomethacin may decrease the excretion rate of Quinidine which could result in a higher serum level.]
[C02CA02, indoramin, Quinidine may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Indoramin.]
[A11HA07, inositol, Inositol may decrease the excretion rate of Quinidine which could result in a higher serum level.]
[N06AX17, milnacipran, The metabolism of Quinidine can be decreased when combined with Milnacipran.]
[A03AA30, piperidolate, The risk or severity of adverse effects can be increased when Quinidine is combined with Piperidolate.]
[R01AA02, cyclopentamine, The risk or severity of adverse effects can be increased when Quinidine is combined with Cyclopentamine.]
[S01XA28, varenicline, The excretion of Varenicline can be decreased when combined with Quinidine.]
[N01BB08, articaine, The risk or severity of methemoglobinemia can be increased when Quinidine is combined with Articaine.]
[A10BH01, sitagliptin, Sitagliptin may decrease the excretion rate of Quinidine which could result in a higher serum level.]
[N05BA12, alprazolam, The metabolism of Alprazolam can be decreased when combined with Quinidine.]
[N05CH02, ramelteon, The serum concentration of Ramelteon can be increased when it is combined with Quinidine.]
[R06AE01, buclizine, The risk or severity of QTc prolongation can be increased when Buclizine is combined with Quinidine.]
[C10AA06, cerivastatin, The metabolism of Quinidine can be increased when combined with Cerivastatin.]
[L01XX35, anagrelide, The risk or severity of QTc prolongation can be increased when Anagrelide is combined with Quinidine.]
[C07AA01, alprenolol, Alprenolol may increase the arrhythmogenic activities of Quinidine.]
[C03BA02, quinethazone, Quinethazone may increase the excretion rate of Quinidine which could result in a lower serum level and potentially a reduction in efficacy.]
[V03AB01, ipecac, The metabolism of Ipecac can be decreased when combined with Quinidine.]
[N06AA13, iprindole, Iprindole may increase the central nervous system depressant (CNS depressant) activities of Quinidine.]
[G04BE01, alprostadil, The excretion of Alprostadil can be decreased when combined with Quinidine.]
[N06AF05, iproniazid, Iproniazid may increase the central nervous system depressant (CNS depressant) activities of Quinidine.]
[J05AB13, penciclovir, The metabolism of Penciclovir can be decreased when combined with Quinidine.]
[N05AA07, chlorproethazine, The risk or severity of QTc prolongation can be increased when Quinidine is combined with Chlorproethazine.]
[N06AF01, isocarboxazid, Isocarboxazid may increase the central nervous system depressant (CNS depressant) activities of Quinidine.]
[R03CC06, isoetharine, The therapeutic efficacy of Isoetharine can be decreased when used in combination with Quinidine.]
[C09AA16, imidapril, Quinidine may decrease the antihypertensive activities of Imidapril.]
[N01AB06, isoflurane, Isoflurane may increase the central nervous system depressant (CNS depressant) activities of Quinidine.]
[S01EB07, isoflurophate, The therapeutic efficacy of Quinidine can be decreased when used in combination with Isoflurophate.]
[N04BX02, entacapone, Entacapone may increase the central nervous system depressant (CNS depressant) activities of Quinidine.]
[J04AC01, isoniazid, The metabolism of Quinidine can be decreased when combined with Isoniazid.]
[J05AX05, inosine pranobex, Inosine pranobex may decrease the excretion rate of Quinidine which could result in a higher serum level.]
[R03CB01, isoproterenol, The therapeutic efficacy of Isoprenaline can be decreased when used in combination with Quinidine.]
[C01DA14, isosorbide mononitrate, Isosorbide mononitrate may decrease the excretion rate of Quinidine which could result in a higher serum level.]
[D10BA01, isotretinoin, Isotretinoin may decrease the excretion rate of Quinidine which could result in a higher serum level.]
[C04AA01, isoxsuprine, The therapeutic efficacy of Isoxsuprine can be decreased when used in combination with Quinidine.]
[B01AE06, bivalirudin, The therapeutic efficacy of Bivalirudin can be increased when used in combination with Quinidine.]
[J01FA07, josamycin, The serum concentration of Quinidine can be increased when it is combined with Josamycin.]
[N06AX18, reboxetine, Reboxetine may increase the central nervous system depressant (CNS depressant) activities of Quinidine.]
[S01AA24, kanamycin, Kanamycin may decrease the excretion rate of Quinidine which could result in a higher serum level.]
[A07BC02, kaolin, Kaolin can cause a decrease in the absorption of Quinidine resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[A02AB01, aluminum hydroxide, Aluminum hydroxide may decrease the excretion rate of Quinidine which could result in a higher serum level.]
[L04AC07, tocilizumab, The metabolism of Quinidine can be increased when combined with Tocilizumab.]
[N01AX03, ketamine, Ketamine may decrease the excretion rate of Quinidine which could result in a higher serum level.]
[C02KD01, ketanserin, Ketanserin may increase the central nervous system depressant (CNS depressant) activities of Quinidine.]
[B01AC22, prasugrel, The therapeutic efficacy of Prasugrel can be increased when used in combination with Quinidine.]
[H02CA04, levoketoconazole, The metabolism of Quinidine can be decreased when combined with Levoketoconazole.]
[J02AB02, ketoconazole, The metabolism of Quinidine can be decreased when combined with Ketoconazole.]
[N05AH03, olanzapine, Olanzapine may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Quinidine.]
[M02AA10, ketoprofen, Ketoprofen may decrease the excretion rate of Quinidine which could result in a higher serum level.]
[V03AC03, deferasirox, The metabolism of Quinidine can be increased when combined with Deferasirox.]
[L04AA24, abatacept, The metabolism of Quinidine can be increased when combined with Abatacept.]
[R06AX25, mizolastine, The risk or severity of QTc prolongation can be increased when Mizolastine is combined with Quinidine.]
[C01CA22, arbutamine, The therapeutic efficacy of Arbutamine can be decreased when used in combination with Quinidine.]
[N04BC09, rotigotine, The metabolism of Rotigotine can be decreased when combined with Quinidine.]
[D10AX03, azelaic acid, Azelaic acid may decrease the excretion rate of Quinidine which could result in a higher serum level.]
[J01MB02, nalidixic acid, The risk or severity of QTc prolongation can be increased when Nalidixic acid is combined with Quinidine.]
[M01AE11, tiaprofenic acid, Tiaprofenic acid may decrease the excretion rate of Quinidine which could result in a higher serum level.]
[C07AG01, labetalol, Labetalol may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Quinidine.]
[N04BB01, amantadine, Amantadine may decrease the excretion rate of Quinidine which could result in a higher serum level.]
[C02AA05, deserpidine, Quinidine may decrease the antihypertensive activities of Deserpidine.]
[A06AD11, lactulose, The therapeutic efficacy of Lactulose can be decreased when used in combination with Quinidine.]
[N07AA30, ambenonium, The therapeutic efficacy of Quinidine can be decreased when used in combination with Ambenonium.]
[A06AX03, lubiprostone, Lubiprostone may decrease the excretion rate of Quinidine which could result in a higher serum level.]
[N03AX18, lacosamide, The metabolism of Quinidine can be decreased when combined with Lacosamide.]
[C03CC01, ethacrynic acid, Etacrynic acid may decrease the excretion rate of Quinidine which could result in a higher serum level.]
[A05AA02, ursodiol, Quinidine may decrease the excretion rate of Ursodeoxycholic acid which could result in a higher serum level.]
[N04BA01, levodopa, The absorption of Levodopa can be decreased when combined with Quinidine.]
[S02DA01, lidocaine, Lidocaine may increase the arrhythmogenic activities of Quinidine.]
[C08EX01, lidoflazine, Quinidine may increase the arrhythmogenic activities of Lidoflazine.]
[J01FF02, lincomycin, The risk or severity of neuromuscular blockade can be increased when Quinidine is combined with Lincomycin.]
[S01AA21, amikacin, Amikacin may decrease the excretion rate of Quinidine which could result in a higher serum level.]
[N06BA13, armodafinil, The metabolism of Quinidine can be increased when combined with Armodafinil.]
[D06AX13, retapamulin, The metabolism of Retapamulin can be decreased when combined with Quinidine.]
[C03DB01, amiloride, Amiloride may increase the excretion rate of Quinidine which could result in a lower serum level and potentially a reduction in efficacy.]
[N02CA07, lisuride, The metabolism of Lisuride can be decreased when combined with Quinidine.]
[N06AA07, lofepramine, Lofepramine may increase the central nervous system depressant (CNS depressant) activities of Quinidine.]
[A07DA03, loperamide, The excretion of Loperamide can be decreased when combined with Quinidine.]
[N05BA06, lorazepam, Lorazepam may decrease the excretion rate of Quinidine which could result in a higher serum level.]
[C10AA02, lovastatin, The metabolism of Lovastatin can be decreased when combined with Quinidine.]
[N05AH01, loxapine, The serum concentration of Quinidine can be increased when it is combined with Loxapine.]
[J01AA04, lymecycline, The risk or severity of neuromuscular blockade can be increased when Lymecycline is combined with Quinidine.]
[G03DC03, lynestrenol, The metabolism of Lynestrenol can be decreased when combined with Quinidine.]
[L01EG01, temsirolimus, The serum concentration of Quinidine can be increased when it is combined with Temsirolimus.]
[B05XA11, magnesium chloride, Magnesium chloride may decrease the excretion rate of Quinidine which could result in a higher serum level.]
[G04BX01, magnesium hydroxide, Magnesium hydroxide may decrease the excretion rate of Quinidine which could result in a higher serum level.]
[A12CC10, magnesium oxide, Magnesium oxide may decrease the excretion rate of Quinidine which could result in a higher serum level.]
[V04CC02, magnesium sulfate, Magnesium sulfate may increase the arrhythmogenic activities of Quinidine.]
[L01BA05, pralatrexate, Pralatrexate may decrease the excretion rate of Quinidine which could result in a higher serum level.]
[L01EA03, nilotinib, The metabolism of Quinidine can be decreased when combined with Nilotinib.]
[V04CX04, mannitol, Mannitol may decrease the excretion rate of Quinidine which could result in a higher serum level.]
[N06AA21, maprotiline, The metabolism of Maprotiline can be decreased when combined with Quinidine.]
[A08AA05, mazindol, Mazindol may increase the central nervous system depressant (CNS depressant) activities of Quinidine.]
[C02BB01, mecamylamine, Mecamylamine may decrease the excretion rate of Quinidine which could result in a higher serum level.]
[L01AA05, mechlorethamine, The therapeutic efficacy of Quinidine can be decreased when used in combination with Mechlorethamine.]
[R06AE05, meclizine, The metabolism of Meclizine can be decreased when combined with Quinidine.]
[M02AA18, meclofenamic acid, Meclofenamic acid may decrease the excretion rate of Quinidine which could result in a higher serum level.]
[N05BA03, medazepam, Medazepam may increase the central nervous system depressant (CNS depressant) activities of Quinidine.]
[C01AA08, medigoxin, The serum concentration of Metildigoxin can be increased when it is combined with Quinidine.]
[A06AB07, cascara sagrada, The therapeutic efficacy of Frangula purshiana bark can be decreased when used in combination with Quinidine.]
[P01BC02, mefloquine, The risk or severity of adverse effects can be increased when Quinidine is combined with Mefloquine.]
[C03BA05, mefruside, Mefruside may increase the excretion rate of Quinidine which could result in a lower serum level and potentially a reduction in efficacy.]
[B01AB06, nadroparin, The therapeutic efficacy of Nadroparin can be increased when used in combination with Quinidine.]
[B01AB05, enoxaparin, The therapeutic efficacy of Enoxaparin can be increased when used in combination with Quinidine.]
[B01AB04, dalteparin, The therapeutic efficacy of Dalteparin can be increased when used in combination with Quinidine.]
[N05CH01, melatonin, The metabolism of Melatonin can be decreased when combined with Quinidine.]
[N06DX01, memantine, Memantine may decrease the excretion rate of Quinidine which could result in a higher serum level.]
[N02AB02, meperidine, The risk or severity of adverse effects can be increased when Quinidine is combined with Meperidine.]
[C01CA11, mephentermine, The therapeutic efficacy of Quinidine can be decreased when used in combination with Mephentermine.]
[N03AB04, mephenytoin, The metabolism of Mephenytoin can be decreased when combined with Quinidine.]
[N03AA01, mephobarbital, The serum concentration of Methylphenobarbital can be increased when it is combined with Quinidine.]
[N01BB03, mepivacaine, The risk or severity of methemoglobinemia can be increased when Quinidine is combined with Mepivacaine.]
[N05BC01, meprobamate, Meprobamate may increase the central nervous system depressant (CNS depressant) activities of Quinidine.]
[N02AX05, meptazinol, The risk or severity of adverse effects can be increased when Quinidine is combined with Meptazinol.]
[G04BX16, tiopronin, Tiopronin may decrease the excretion rate of Quinidine which could result in a higher serum level.]
[L02BG01, aminoglutethimide, The metabolism of Quinidine can be increased when combined with Aminoglutethimide.]
[C03BC01, mersalyl, Mersalyl may decrease the excretion rate of Quinidine which could result in a higher serum level.]
[N05AC03, mesoridazine, The risk or severity of QTc prolongation can be increased when Quinidine is combined with Mesoridazine.]
[N05AX13, paliperidone, Quinidine may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Paliperidone.]
[C01CA09, metaraminol, The therapeutic efficacy of Metaraminol can be decreased when used in combination with Quinidine.]
[A10BA02, metformin, Metformin may decrease the excretion rate of Quinidine which could result in a higher serum level.]
[A04AA04, dolasetron, The risk or severity of QTc prolongation can be increased when Dolasetron is combined with Quinidine.]
[H01CB03, lanreotide, The metabolism of Quinidine can be decreased when combined with Lanreotide.]
[J01AA05, methacycline, The risk or severity of neuromuscular blockade can be increased when Quinidine is combined with Metacycline.]
[N07BC02, methadone, The risk or severity of adverse effects can be increased when Quinidine is combined with Methadone.]
[N06BA03, methamphetamine, The therapeutic efficacy of Quinidine can be decreased when used in combination with Metamfetamine.]
[A03AB07, methantheline, The risk or severity of adverse effects can be increased when Quinidine is combined with Methantheline.]
[R06AC05, methapyrilene, Methapyrilene may increase the central nervous system depressant (CNS depressant) activities of Quinidine.]
[N05CM01, methaqualone, Methaqualone may increase the central nervous system depressant (CNS depressant) activities of Quinidine.]
[J05AF05, lamivudine, Lamivudine may decrease the excretion rate of Quinidine which could result in a higher serum level.]
[N03AA30, metharbital, Metharbital may increase the central nervous system depressant (CNS depressant) activities of Quinidine.]
[S01EC05, methazolamide, The excretion of Quinidine can be decreased when combined with Methazolamide.]
[G02CB05, metergoline, Metergoline may increase the central nervous system depressant (CNS depressant) activities of Quinidine.]
[H03BB02, methimazole, The metabolism of Quinidine can be decreased when combined with Methimazole.]
[L01BA04, pemetrexed, Quinidine may decrease the excretion rate of Pemetrexed which could result in a higher serum level.]
[M03BA03, methocarbamol, Methocarbamol may increase the central nervous system depressant (CNS depressant) activities of Quinidine.]
[N05CA15, methohexital, Methohexital may increase the central nervous system depressant (CNS depressant) activities of Quinidine.]
[A11HA02, pyridoxine, Pyridoxine may decrease the excretion rate of Quinidine which could result in a higher serum level.]
[N02BG08, ziconotide, Quinidine may increase the arrhythmogenic activities of Ziconotide.]
[L04AX03, methotrexate, The metabolism of Methotrexate can be decreased when combined with Quinidine.]
[N05AA02, methotrimeprazine, Quinidine may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Methotrimeprazine.]
[C01CA10, methoxamine, The therapeutic efficacy of Methoxamine can be decreased when used in combination with Quinidine.]
[D05BA02, methoxsalen, Methoxsalen may decrease the excretion rate of Quinidine which could result in a higher serum level.]
[N02BG09, methoxyflurane, The metabolism of Methoxyflurane can be decreased when combined with Quinidine.]
[C03AA08, methyclothiazide, Methyclothiazide may increase the excretion rate of Quinidine which could result in a lower serum level and potentially a reduction in efficacy.]
[A06AC06, methylcellulose, The therapeutic efficacy of Methylcellulose can be decreased when used in combination with Quinidine.]
[C02AB01, methyldopa, Methyldopa may decrease the excretion rate of Quinidine which could result in a higher serum level.]
[V04CG05, methylene blue, The serum concentration of Quinidine can be increased when it is combined with Methylene blue.]
[G02AB01, methylergonovine, The metabolism of Quinidine can be decreased when combined with Methylergometrine.]
[R03DA05, aminophylline, The serum concentration of Aminophylline can be increased when it is combined with Quinidine.]
[N06BA04, methylphenidate, The risk or severity of hypertension can be increased when Methylphenidate is combined with Quinidine.]
[H02AB04, methylprednisolone, The metabolism of Quinidine can be increased when combined with Methylprednisolone.]
[N03AF03, rufinamide, The metabolism of Quinidine can be increased when combined with Rufinamide.]
[G03EK01, methyltestosterone, Methyltestosterone may decrease the excretion rate of Quinidine which could result in a higher serum level.]
[N05CE02, methyprylon, Methyprylon may increase the central nervous system depressant (CNS depressant) activities of Quinidine.]
[N02CA04, methysergide, The metabolism of Quinidine can be decreased when combined with Methysergide.]
[A03FA01, metoclopramide, The therapeutic efficacy of Metoclopramide can be decreased when used in combination with Quinidine.]
[C03BA08, metolazone, Metolazone may decrease the excretion rate of Quinidine which could result in a higher serum level.]
[C07AB02, metoprolol, Metoprolol may increase the arrhythmogenic activities of Quinidine.]
[P01AB01, metronidazole, The metabolism of Quinidine can be decreased when combined with Metronidazole.]
[V04CD01, metyrapone, The metabolism of Quinidine can be increased when combined with Metyrapone.]
[C01BB02, mexiletine, Mexiletine may increase the arrhythmogenic activities of Quinidine.]
[N06AX03, mianserin, Mianserin may increase the anticholinergic activities of Quinidine.]
[S02AA13, miconazole, The metabolism of Quinidine can be decreased when combined with Miconazole.]
[N02BB03, aminopyrine, The metabolism of Aminophenazone can be decreased when combined with Quinidine.]
[B01AB07, parnaparin, The therapeutic efficacy of Parnaparin can be increased when used in combination with Quinidine.]
[N05CD08, midazolam, The serum concentration of Midazolam can be increased when it is combined with Quinidine.]
[C01CA17, midodrine, The therapeutic efficacy of Midodrine can be decreased when used in combination with Quinidine.]
[G03XB01, mifepristone, The serum concentration of Quinidine can be increased when it is combined with Mifepristone.]
[B01AB10, tinzaparin, The therapeutic efficacy of Tinzaparin can be increased when used in combination with Quinidine.]
[A06AA01, mineral oil, The therapeutic efficacy of Mineral oil can be decreased when used in combination with Quinidine.]
[J05AH01, zanamivir, Zanamivir may decrease the excretion rate of Quinidine which could result in a higher serum level.]
[C09CA03, valsartan, The metabolism of Valsartan can be decreased when combined with Quinidine.]
[J01AA08, minocycline, The risk or severity of neuromuscular blockade can be increased when Quinidine is combined with Minocycline.]
[D11AX01, minoxidil, Quinidine may decrease the antihypertensive activities of Minoxidil.]
[J01FA11, miocamycin, The serum concentration of Quinidine can be increased when it is combined with Miocamycin.]
[L01XX23, mitotane, The metabolism of Quinidine can be increased when combined with Mitotane.]
[N06BA12, lisdexamfetamine, The therapeutic efficacy of Quinidine can be decreased when used in combination with Lisdexamfetamine.]
[N05AE02, molindone, Molindone may increase the central nervous system depressant (CNS depressant) activities of Quinidine.]
[L03AC01, aldesleukin, The metabolism of Quinidine can be decreased when combined with Aldesleukin.]
[C01BD01, amiodarone, The serum concentration of Quinidine can be increased when it is combined with Amiodarone.]
[N06AA09, amitriptyline, The metabolism of Amitriptyline can be decreased when combined with Quinidine.]
[N02AA01, morphine, The risk or severity of adverse effects can be increased when Quinidine is combined with Morphine.]
[A04AA05, palonosetron, The metabolism of Palonosetron can be decreased when combined with Quinidine.]
[J01DD06, moxalactam, Latamoxef may decrease the excretion rate of Quinidine which could result in a higher serum level.]
[L04AB05, certolizumab pegol, The metabolism of Quinidine can be increased when combined with Certolizumab pegol.]
[B02BX05, eltrombopag, The metabolism of Eltrombopag can be decreased when combined with Quinidine.]
[G04BA01, ammonium chloride, Ammonium chloride may decrease the excretion rate of Quinidine which could result in a higher serum level.]
[L01EX03, pazopanib, The serum concentration of Pazopanib can be increased when it is combined with Quinidine.]
[L04AA06, mycophenolic acid, Mycophenolic acid may decrease the excretion rate of Quinidine which could result in a higher serum level.]
[M03AC03, vecuronium, The therapeutic efficacy of Vecuronium can be increased when used in combination with Quinidine.]
[N05CA02, amobarbital, The metabolism of Quinidine can be increased when combined with Amobarbital.]
[P01BA06, amodiaquine, The risk or severity of QTc prolongation can be increased when Amodiaquine is combined with Quinidine.]
[G04CA04, silodosin, The excretion of Silodosin can be decreased when combined with Quinidine.]
[R03BB01, ipratropium bromide, The risk or severity of adverse effects can be increased when Quinidine is combined with Ipratropium.]
[G03XC01, raloxifene, The metabolism of Quinidine can be decreased when combined with Raloxifene.]
[N06AA17, amoxapine, Amoxapine may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Quinidine.]
[N03AB05, fosphenytoin, The serum concentration of Quinidine can be decreased when it is combined with Fosphenytoin.]
[C07AA12, nadolol, Quinidine may increase the arrhythmogenic activities of Nadolol.]
[J01CA04, amoxicillin, Amoxicillin may decrease the excretion rate of Quinidine which could result in a higher serum level.]
[N04BC04, ropinirole, The risk or severity of adverse effects can be increased when Quinidine is combined with Ropinirole.]
[J01CF06, nafcillin, The metabolism of Quinidine can be increased when combined with Nafcillin.]
[C04AX21, nafronyl, Naftidrofuryl may increase the central nervous system depressant (CNS depressant) activities of Quinidine.]
[N02AF02, nalbuphine, The risk or severity of adverse effects can be increased when Quinidine is combined with Nalbuphine.]
[V03AB15, naloxone, The metabolism of Quinidine can be decreased when combined with Naloxone.]
[N07BB04, naltrexone, The risk or severity of adverse effects can be increased when Quinidine is combined with Naltrexone.]
[L04AC03, anakinra, The metabolism of Quinidine can be increased when combined with Anakinra.]
[S01GA01, naphazoline, The risk or severity of Cardiac Arrhythmia can be increased when Naphazoline is combined with Quinidine.]
[N06BA01, amphetamine, The therapeutic efficacy of Quinidine can be decreased when used in combination with Amphetamine.]
[M02AA12, naproxen, The metabolism of Naproxen can be decreased when combined with Quinidine.]
[A10BG01, troglitazone, The metabolism of Quinidine can be increased when combined with Troglitazone.]
[N06AX21, duloxetine, The metabolism of Duloxetine can be decreased when combined with Quinidine.]
[N04BX01, tolcapone, Tolcapone may decrease the excretion rate of Quinidine which could result in a higher serum level.]
[L01CD02, docetaxel, The metabolism of Docetaxel can be decreased when combined with Quinidine.]
[S03AA01, neomycin, Neomycin may decrease the excretion rate of Quinidine which could result in a higher serum level.]
[N01AH06, remifentanil, The risk or severity of adverse effects can be increased when Quinidine is combined with Remifentanil.]
[A10BX02, repaglinide, Quinidine may decrease the excretion rate of Repaglinide which could result in a higher serum level.]
[C01CX08, levosimendan, Quinidine may increase the arrhythmogenic activities of Levosimendan.]
[B01AC17, tirofiban, Tirofiban may decrease the excretion rate of Quinidine which could result in a higher serum level.]
[S01EB06, neostigmine, The therapeutic efficacy of Quinidine can be decreased when used in combination with Neostigmine.]
[N05AX14, iloperidone, The metabolism of Iloperidone can be decreased when combined with Quinidine.]
[J02AA01, amphotericin B, Amphotericin B may decrease the excretion rate of Quinidine which could result in a higher serum level.]
[S01AA19, ampicillin, Ampicillin may decrease the excretion rate of Quinidine which could result in a higher serum level.]
[L03AX16, plerixafor, Plerixafor may decrease the excretion rate of Quinidine which could result in a higher serum level.]
[S01AA23, netilmicin, Netilmicin may decrease the excretion rate of Quinidine which could result in a higher serum level.]
[N06AX23, desvenlafaxine, The metabolism of Quinidine can be decreased when combined with Desvenlafaxine.]
[C09CA07, telmisartan, Quinidine may decrease the excretion rate of Telmisartan which could result in a higher serum level.]
[J05AB11, valacyclovir, Valaciclovir may decrease the excretion rate of Quinidine which could result in a higher serum level.]
[C01CE01, inamrinone, Amrinone may decrease the excretion rate of Quinidine which could result in a higher serum level.]
[C10AD02, niacin, The metabolism of Quinidine can be decreased when combined with Niacin.]
[N06AF02, nialamide, Nialamide may increase the central nervous system depressant (CNS depressant) activities of Quinidine.]
[C08CA04, nicardipine, Nicardipine may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Quinidine.]
[C04AE02, nicergoline, Nicergoline may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Quinidine.]
[P02DA01, niclosamide, The metabolism of Niclosamide can be decreased when combined with Quinidine.]
[N07BA01, nicotine, The risk or severity of adverse effects can be increased when Quinidine is combined with Nicotine.]
[C08CA05, nifedipine, Quinidine may increase the arrhythmogenic activities of Nifedipine.]
[M02AA17, niflumic acid, Niflumic acid may decrease the excretion rate of Quinidine which could result in a higher serum level.]
[C08CA06, nimodipine, Nimodipine may increase the arrhythmogenic activities of Quinidine.]
[C08CA07, nisoldipine, Nisoldipine may increase the arrhythmogenic activities of Quinidine.]
[N05CD02, nitrazepam, Nitrazepam may increase the central nervous system depressant (CNS depressant) activities of Quinidine.]
[C08CA08, nitrendipine, Quinidine may increase the arrhythmogenic activities of Nitrendipine.]
[R07AX01, nitric oxide, Nitric Oxide may decrease the excretion rate of Quinidine which could result in a higher serum level.]
[J01XE01, nitrofurantoin, Nitrofurantoin may decrease the excretion rate of Quinidine which could result in a higher serum level.]
[N05CF03, zaleplon, The metabolism of Quinidine can be decreased when combined with Zaleplon.]
[N04BC05, pramipexole, Pramipexole may decrease the excretion rate of Quinidine which could result in a higher serum level.]
[C02DD01, nitroprusside, Nitroprusside may decrease the excretion rate of Quinidine which could result in a higher serum level.]
[N01AX13, nitrous oxide, Nitrous oxide may increase the central nervous system depressant (CNS depressant) activities of Quinidine.]
[N06AX04, nomifensine, Nomifensine may increase the central nervous system depressant (CNS depressant) activities of Quinidine.]
[C01CA03, norepinephrine, The therapeutic efficacy of Norepinephrine can be decreased when used in combination with Quinidine.]
[G03DC02, norethindrone, The metabolism of Quinidine can be decreased when combined with Norethisterone.]
[S01AE02, norfloxacin, The risk or severity of QTc prolongation can be increased when Norfloxacin is combined with Quinidine.]
[C02KX01, bosentan, The metabolism of Quinidine can be increased when combined with Bosentan.]
[N06AA10, nortriptyline, Nortriptyline may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Quinidine.]
[R05DA07, noscapine, The metabolism of Quinidine can be decreased when combined with Noscapine.]
[A16AX07, sapropterin, The serum concentration of Quinidine can be increased when it is combined with Sapropterin.]
[G02CA02, nylidrin, Quinidine may increase the arrhythmogenic activities of Nylidrin.]
[B01AB08, reviparin, The therapeutic efficacy of Reviparin can be increased when used in combination with Quinidine.]
[H01CB02, octreotide, The serum concentration of Quinidine can be increased when it is combined with Octreotide.]
[S02AA16, ofloxacin, The risk or severity of QTc prolongation can be increased when Ofloxacin is combined with Quinidine.]
[J01FA05, oleandomycin, The serum concentration of Quinidine can be increased when it is combined with Oleandomycin.]
[L04AC04, rilonacept, The metabolism of Quinidine can be increased when combined with Rilonacept.]
[A02BC01, omeprazole, The metabolism of Quinidine can be increased when combined with Omeprazole.]
[N06AA05, opipramol, Opipramol may increase the central nervous system depressant (CNS depressant) activities of Quinidine.]
[N02AA02, opium, The risk or severity of adverse effects can be increased when Quinidine is combined with Opium.]
[R03CB03, metaproterenol, The therapeutic efficacy of Orciprenaline can be decreased when used in combination with Quinidine.]
[B01AD07, reteplase, The therapeutic efficacy of Reteplase can be increased when used in combination with Quinidine.]
[B01AD09, ancrod, The therapeutic efficacy of Ancrod can be increased when used in combination with Quinidine.]
[G04CA02, tamsulosin, Tamsulosin may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Quinidine.]
[C01AC01, ouabain, The serum concentration of Ouabain can be increased when it is combined with Quinidine.]
[J01CF04, oxacillin, Oxacillin may decrease the excretion rate of Quinidine which could result in a higher serum level.]
[N05BA04, oxazepam, Oxazepam may decrease the excretion rate of Quinidine which could result in a higher serum level.]
[J01MB05, oxolinic acid, The risk or severity of QTc prolongation can be increased when Oxolinic acid is combined with Quinidine.]
[C07AA02, oxprenolol, Quinidine may increase the arrhythmogenic activities of Oxprenolol.]
[N02AA05, oxycodone, The risk or severity of adverse effects can be increased when Quinidine is combined with Oxycodone.]
[C01DX03, oxyfedrine, The therapeutic efficacy of Oxyfedrine can be decreased when used in combination with Quinidine.]
[S01GA04, oxymetazoline, The therapeutic efficacy of Oxymetazoline can be decreased when used in combination with Quinidine.]
[N02AA11, oxymorphone, The risk or severity of adverse effects can be increased when Quinidine is combined with Oxymorphone.]
[N05AE01, oxypertine, Oxypertine may increase the central nervous system depressant (CNS depressant) activities of Quinidine.]
[S01BC02, oxyphenbutazone, Oxyphenbutazone may decrease the excretion rate of Quinidine which could result in a higher serum level.]
[A03AB03, oxyphenonium, The risk or severity of adverse effects can be increased when Oxyphenonium is combined with Quinidine.]
[S01AA04, oxytetracycline, The excretion of Oxytetracycline can be decreased when combined with Quinidine.]
[H01BB02, oxytocin, The risk or severity of QTc prolongation can be increased when Oxytocin is combined with Quinidine.]
[V04CH30, 4-aminohippuric acid, The excretion of Aminohippuric acid can be decreased when combined with Quinidine.]
[N05AH05, asenapine, Quinidine may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Asenapine.]
[B01AB09, danaparoid, The therapeutic efficacy of Danaparoid can be increased when used in combination with Quinidine.]
[N02AX06, tapentadol, The risk or severity of adverse effects can be increased when Quinidine is combined with Tapentadol.]
[M03AC01, pancuronium, The therapeutic efficacy of Pancuronium can be increased when used in combination with Quinidine.]
[J04AB30, capreomycin, Capreomycin may decrease the excretion rate of Quinidine which could result in a higher serum level.]
[G04BE02, papaverine, The risk or severity of QTc prolongation can be increased when Papaverine is combined with Quinidine.]
[N05CC05, paraldehyde, Paraldehyde may increase the central nervous system depressant (CNS depressant) activities of Quinidine.]
[H02AB05, paramethasone, The metabolism of Quinidine can be increased when combined with Paramethasone.]
[C02KC01, pargyline, Pargyline may increase the central nervous system depressant (CNS depressant) activities of Quinidine.]
[A07AA06, paromomycin, Paromomycin may decrease the excretion rate of Quinidine which could result in a higher serum level.]
[J01MA03, pefloxacin, The risk or severity of QTc prolongation can be increased when Pefloxacin is combined with Quinidine.]
[G04BD11, fesoterodine, The metabolism of Fesoterodine can be decreased when combined with Quinidine.]
[C07AA23, penbutolol, The metabolism of Penbutolol can be decreased when combined with Quinidine.]
[N05AG03, penfluridol, Quinidine may increase the arrhythmogenic activities of Penfluridol.]
[M01CC01, penicillamine, The excretion of Penicillamine can be decreased when combined with Quinidine.]
[S01AA14, penicillin G, The excretion of Benzylpenicillin can be decreased when combined with Quinidine.]
[J01CE09, penicillin G procaine, Procaine benzylpenicillin may decrease the excretion rate of Quinidine which could result in a higher serum level.]
[N02AD01, pentazocine, The risk or severity of adverse effects can be increased when Quinidine is combined with Pentazocine.]
[N05CA01, pentobarbital, The metabolism of Quinidine can be increased when combined with Pentobarbital.]
[L01XX08, pentostatin, Pentostatin may decrease the excretion rate of Quinidine which could result in a higher serum level.]
[C04AD03, pentoxifylline, The serum concentration of Pentoxifylline can be increased when it is combined with Quinidine.]
[N05AB10, perazine, The risk or severity of QTc prolongation can be increased when Quinidine is combined with Perazine.]
[N04BC02, pergolide, The therapeutic efficacy of Pergolide can be decreased when used in combination with Quinidine.]
[C08EX02, perhexiline, Quinidine may increase the arrhythmogenic activities of Perhexiline.]
[N05AB03, perphenazine, The risk or severity of QTc prolongation can be increased when Quinidine is combined with Perphenazine.]
[N02BE03, phenacetin, The metabolism of Phenacetin can be decreased when combined with Quinidine.]
[N02AD02, phenazocine, The risk or severity of adverse effects can be increased when Quinidine is combined with Phenazocine.]
[G04BX06, phenazopyridine, Phenazopyridine may decrease the excretion rate of Quinidine which could result in a higher serum level.]
[N06AF03, phenelzine, Phenelzine may decrease the excretion rate of Quinidine which could result in a higher serum level.]
[A10BA01, phenformin, The metabolism of Phenformin can be decreased when combined with Quinidine.]
[B01AA02, phenindione, The therapeutic efficacy of Phenindione can be increased when used in combination with Quinidine.]
[R06AB05, pheniramine, The risk or severity of QTc prolongation can be increased when Pheniramine is combined with Quinidine.]
[N03AA02, phenobarbital, The serum concentration of Phenobarbital can be increased when it is combined with Quinidine.]
[A06AB01, oxyphenisatin, The therapeutic efficacy of Oxyphenisatin can be decreased when used in combination with Quinidine.]
[N01AH04, phenoperidine, The risk or severity of adverse effects can be increased when Quinidine is combined with Phenoperidine.]
[C04AX02, phenoxybenzamine, Quinidine may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Phenoxybenzamine.]
[B01AA04, phenprocoumon, The therapeutic efficacy of Phenprocoumon can be increased when used in combination with Quinidine.]
[A08AA01, phentermine, The therapeutic efficacy of Quinidine can be decreased when used in combination with Phentermine.]
[V03AB36, phentolamine, Phentolamine may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Quinidine.]
[M02AA01, phenylbutazone, The metabolism of Quinidine can be increased when combined with Phenylbutazone.]
[S01GA05, phenylephrine, The therapeutic efficacy of Phenylephrine can be decreased when used in combination with Quinidine.]
[R01BA01, phenylpropanolamine, The therapeutic efficacy of Phenylpropanolamine can be decreased when used in combination with Quinidine.]
[N03AB02, phenytoin, The serum concentration of Quinidine can be decreased when it is combined with Phenytoin.]
[L04AB06, golimumab, The metabolism of Quinidine can be increased when combined with Golimumab.]
[S01AE05, levofloxacin, The risk or severity of QTc prolongation can be increased when Levofloxacin is combined with Quinidine.]
[N07BB03, acamprosate, The excretion of Acamprosate can be decreased when combined with Quinidine.]
[V03AB19, physostigmine, The therapeutic efficacy of Quinidine can be decreased when used in combination with Physostigmine.]
[L02BB03, bicalutamide, The metabolism of Bicalutamide can be decreased when combined with Quinidine.]
[B02BA01, vitamin K1, Phylloquinone may decrease the excretion rate of Quinidine which could result in a higher serum level.]
[J05AB12, cidofovir, Cidofovir may decrease the excretion rate of Quinidine which could result in a higher serum level.]
[C08CX01, mibefradil, Quinidine may increase the arrhythmogenic activities of Mibefradil.]
[N05AG02, pimozide, The metabolism of Pimozide can be decreased when combined with Quinidine.]
[C07AA03, pindolol, The metabolism of Pindolol can be decreased when combined with Quinidine.]
[C10AA05, atorvastatin, The risk or severity of myopathy and rhabdomyolysis can be increased when Quinidine is combined with Atorvastatin.]
[J01CA12, piperacillin, Piperacillin may decrease the excretion rate of Quinidine which could result in a higher serum level.]
[J05AE01, saquinavir, The metabolism of Quinidine can be increased when combined with Saquinavir.]
[P02CB01, piperazine, The metabolism of Piperazine can be decreased when combined with Quinidine.]
[N05AC04, pipothiazine, The risk or severity of QTc prolongation can be increased when Quinidine is combined with Pipotiazine.]
[N06BX03, piracetam, Piracetam may decrease the excretion rate of Quinidine which could result in a higher serum level.]
[C09CA02, eprosartan, Quinidine may decrease the antihypertensive activities of Eprosartan.]
[A02BX03, pirenzepine, The risk or severity of adverse effects can be increased when Pirenzepine is combined with Quinidine.]
[N02AC03, pirinitramide, The risk or severity of adverse effects can be increased when Quinidine is combined with Piritramide.]
[S01BC06, piroxicam, Piroxicam may decrease the excretion rate of Quinidine which could result in a higher serum level.]
[J01DD16, cefditoren, Cefditoren may decrease the excretion rate of Quinidine which could result in a higher serum level.]
[J01MA11, grepafloxacin, The risk or severity of QTc prolongation can be increased when Grepafloxacin is combined with Quinidine.]
[N02CX01, pizotyline, Quinidine may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Pizotifen.]
[J05AG02, delavirdine, The metabolism of Quinidine can be decreased when combined with Delavirdine.]
[C09CA04, irbesartan, The metabolism of Quinidine can be decreased when combined with Irbesartan.]
[N05CA22, proxibarbal, Proxibarbal may increase the central nervous system depressant (CNS depressant) activities of Quinidine.]
[B01AC13, abciximab, The therapeutic efficacy of Abciximab can be increased when used in combination with Quinidine.]
[D05AX05, tazarotene, The metabolism of Tazarotene can be decreased when combined with Quinidine.]
[S01XA13, alteplase, The therapeutic efficacy of Alteplase can be increased when used in combination with Quinidine.]
[A10BG02, rosiglitazone, Rosiglitazone may decrease the excretion rate of Quinidine which could result in a higher serum level.]
[L02BG03, anastrozole, The metabolism of Anastrozole can be decreased when combined with Quinidine.]
[A06AD15, polyethylene glycols, The therapeutic efficacy of Polyethylene glycol can be decreased when used in combination with Quinidine.]
[A03AE01, alosetron, The metabolism of Alosetron can be decreased when combined with Quinidine.]
[L04AC08, canakinumab, The metabolism of Quinidine can be increased when combined with Canakinumab.]
[C03AA05, polythiazide, The excretion of Polythiazide can be decreased when combined with Quinidine.]
[J05AE03, ritonavir, The serum concentration of Quinidine can be increased when it is combined with Ritonavir.]
[A10BH03, saxagliptin, Saxagliptin may decrease the excretion rate of Quinidine which could result in a higher serum level.]
[B05XA01, potassium chloride, The risk or severity of gastrointestinal ulceration can be increased when Quinidine is combined with Potassium chloride.]
[C10AA08, pitavastatin, Quinidine may decrease the excretion rate of Pitavastatin which could result in a higher serum level.]
[C07AB01, practolol, Quinidine may increase the arrhythmogenic activities of Practolol.]
[C01BA08, prajmaline, Quinidine may increase the arrhythmogenic activities of Prajmaline.]
[N05BA11, prazepam, Prazepam may increase the central nervous system depressant (CNS depressant) activities of Quinidine.]
[P02BA01, praziquantel, The metabolism of Quinidine can be decreased when combined with Praziquantel.]
[C02CA01, prazosin, Prazosin may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Quinidine.]
[S03BA02, prednisolone, The metabolism of Quinidine can be increased when combined with Prednisolone.]
[H02AB07, prednisone, Prednisone may decrease the excretion rate of Quinidine which could result in a higher serum level.]
[R06AX05, antazoline, The risk or severity of QTc prolongation can be increased when Antazoline is combined with Quinidine.]
[C01DX02, prenylamine, Quinidine may increase the arrhythmogenic activities of Prenylamine.]
[N01BB04, prilocaine, The risk or severity of methemoglobinemia can be increased when Quinidine is combined with Prilocaine.]
[P01BA03, primaquine, The metabolism of Quinidine can be decreased when combined with Primaquine.]
[N03AA03, primidone, The serum concentration of Primidone can be increased when it is combined with Quinidine.]
[M04AB01, probenecid, The metabolism of Quinidine can be increased when combined with Probenecid.]
[C10AX02, probucol, The risk or severity of QTc prolongation can be increased when Probucol is combined with Quinidine.]
[C01BA02, procainamide, Quinidine may increase the arrhythmogenic activities of Procainamide.]
[S01HA05, procaine, The risk or severity of methemoglobinemia can be increased when Quinidine is combined with Procaine.]
[L01XB01, procarbazine, Procarbazine may increase the central nervous system depressant (CNS depressant) activities of Quinidine.]
[C10AB05, fenofibrate, Fenofibrate may decrease the excretion rate of Quinidine which could result in a higher serum level.]
[N05AB04, prochlorperazine, The risk or severity of QTc prolongation can be increased when Quinidine is combined with Prochlorperazine.]
[N04AA04, procyclidine, The risk or severity of adverse effects can be increased when Procyclidine is combined with Quinidine.]
[G03DA04, progesterone, The metabolism of Quinidine can be decreased when combined with Progesterone.]
[N05AA03, promazine, Promazine may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Quinidine.]
[R06AD02, promethazine, The risk or severity of QTc prolongation can be increased when Quinidine is combined with Promethazine.]
[C01BC03, propafenone, Quinidine may decrease the QTc-prolonging activities of Propafenone.]
[N01AX04, propanidid, Propanidid may increase the central nervous system depressant (CNS depressant) activities of Quinidine.]
[A03AB05, propantheline, Propantheline may decrease the excretion rate of Quinidine which could result in a higher serum level.]
[R06AX26, fexofenadine, The excretion of Fexofenadine can be decreased when combined with Quinidine.]
[N05AC01, periciazine, Quinidine may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Periciazine.]
[N05CM06, propiomazine, Propiomazine may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Quinidine.]
[L01XH02, romidepsin, The serum concentration of Romidepsin can be increased when it is combined with Quinidine.]
[N01AX10, propofol, The metabolism of Quinidine can be decreased when combined with Propofol.]
[N02AC04, propoxyphene, The risk or severity of adverse effects can be increased when Quinidine is combined with Dextropropoxyphene.]
[C07AA05, propranolol, The serum concentration of Propranolol can be increased when it is combined with Quinidine.]
[C01AB01, proscillaridin, The serum concentration of Proscillaridin can be increased when it is combined with Quinidine.]
[N02CC04, rizatriptan, Rizatriptan may decrease the excretion rate of Quinidine which could result in a higher serum level.]
[B01AC09, epoprostenol, The therapeutic efficacy of Epoprostenol can be increased when used in combination with Quinidine.]
[R03DC03, montelukast, The metabolism of Montelukast can be decreased when combined with Quinidine.]
[N06AA11, protriptyline, Protriptyline may increase the central nervous system depressant (CNS depressant) activities of Quinidine.]
[R01BA02, pseudoephedrine, The therapeutic efficacy of Quinidine can be decreased when used in combination with Pseudoephedrine.]
[N05AX12, aripiprazole, Quinidine may decrease the excretion rate of Aripiprazole which could result in a higher serum level.]
[N07XX07, dalfampridine, The risk or severity of seizure can be increased when Quinidine is combined with Dalfampridine.]
[A03AB15, diphemanil, The risk or severity of adverse effects can be increased when Quinidine is combined with Diphemanil.]
[A03AB09, isopropamide, The risk or severity of adverse effects can be increased when Quinidine is combined with Isopropamide.]
[S01FA03, methscopolamine, The risk or severity of adverse effects can be increased when Quinidine is combined with Methscopolamine.]
[N05CA07, talbutal, Talbutal may increase the central nervous system depressant (CNS depressant) activities of Quinidine.]
[N05CA09, vinbarbital, Vinbarbital may increase the central nervous system depressant (CNS depressant) activities of Quinidine.]
[N05BB02, captodiamine, Captodiame may increase the central nervous system depressant (CNS depressant) activities of Quinidine.]
[M03BA04, styramate, Styramate may increase the central nervous system depressant (CNS depressant) activities of Quinidine.]
[P02CC01, pyrantel, The therapeutic efficacy of Pyrantel can be increased when used in combination with Quinidine.]
[J04AK01, pyrazinamide, Pyrazinamide may decrease the excretion rate of Quinidine which could result in a higher serum level.]
[N07AA02, pyridostigmine, The therapeutic efficacy of Quinidine can be decreased when used in combination with Pyridostigmine.]
[R06AC01, pyrilamine, Mepyramine may increase the central nervous system depressant (CNS depressant) activities of Quinidine.]
[N07XX04, sodium oxybate, Sodium oxybate may increase the central nervous system depressant (CNS depressant) activities of Quinidine.]
[P01BC01, quinine, The serum concentration of Quinidine can be increased when it is combined with Quinine.]
[A02BA02, ranitidine, The metabolism of Ranitidine can be decreased when combined with Quinidine.]
[C02AA01, rescinnamine, Quinidine may decrease the antihypertensive activities of Rescinnamine.]
[C02AA02, reserpine, The risk or severity of adverse effects can be increased when Reserpine is combined with Quinidine.]
[J05AP01, ribavirin, Ribavirin may decrease the excretion rate of Quinidine which could result in a higher serum level.]
[J04AB02, rifampin, The serum concentration of Quinidine can be decreased when it is combined with Rifampicin.]
[R03AC05, rimiterol, The therapeutic efficacy of Rimiterol can be decreased when used in combination with Quinidine.]
[G02CA01, ritodrine, The therapeutic efficacy of Ritodrine can be decreased when used in combination with Quinidine.]
[N06AX01, 5-hydroxytryptophan, Oxitriptan may increase the central nervous system depressant (CNS depressant) activities of Quinidine.]
[J01AA09, rolitetracycline, The risk or severity of neuromuscular blockade can be increased when Quinidine is combined with Rolitetracycline.]
[J01FA06, roxithromycin, The metabolism of Quinidine can be decreased when combined with Roxithromycin.]
[N02BA05, salicylamide, Salicylamide may decrease the excretion rate of Quinidine which could result in a higher serum level.]
[A07EC01, sulfasalazine, Sulfasalazine may decrease the excretion rate of Quinidine which could result in a higher serum level.]
[S01BC08, salicylic acid, Salicylic acid may decrease the excretion rate of Quinidine which could result in a higher serum level.]
[S01FA02, scopolamine, Scopolamine may increase the central nervous system depressant (CNS depressant) activities of Quinidine.]
[N05CA06, secobarbital, The metabolism of Quinidine can be increased when combined with Secobarbital.]
[V04CK01, secretin, The therapeutic efficacy of Secretin porcine can be decreased when used in combination with Quinidine.]
[N04BD01, selegiline, The metabolism of Selegiline can be decreased when combined with Quinidine.]
[J01GB08, sisomicin, Sisomicin may decrease the excretion rate of Quinidine which could result in a higher serum level.]
[A12CD01, sodium fluoride, Sodium fluoride may decrease the excretion rate of Quinidine which could result in a higher serum level.]
[H01CB01, somatostatin, The metabolism of Quinidine can be decreased when combined with Somatostatin.]
[V04CC01, sorbitol, Sorbitol may decrease the excretion rate of Quinidine which could result in a higher serum level.]
[C07AA07, sotalol, Sotalol may increase the arrhythmogenic activities of Quinidine.]
[L01CD04, cabazitaxel, The serum concentration of Cabazitaxel can be increased when it is combined with Quinidine.]
[C03DA01, spironolactone, Quinidine may decrease the excretion rate of Spironolactone which could result in a higher serum level.]
[N05AL01, sulpiride, QT prolonging agents - QT prolonging agents]
[N05AC02, thioridazine, QT prolonging agents - QT prolonging agents]
[L01EX04, vandetanib, QT prolonging agents - QT prolonging agents]
[N06DA02, donepezil, QT prolonging agents - QT prolonging agents]
[S01AE07, moxifloxacin, QT prolonging agents - QT prolonging agents]
[C08EA02, bepridil, QT prolonging agents - QT prolonging agents]
[L01XX27, arsenic trioxide, QT prolonging agents - QT prolonging agents]
[J01MA09, sparfloxacin, QT prolonging agents - QT prolonging agents]
[S01AA26, azithromycin, QT prolonging agents - QT prolonging agents]
[B01AC23, cilostazol, QT prolonging agents - QT prolonging agents]
[J01FA09, clarithromycin, QT prolonging agents - QT prolonging agents]
[S01AE06, gatifloxacin, QT prolonging agents - QT prolonging agents]
[C01BD07, dronedarone, QT prolonging agents - QT prolonging agents]
[L01DB04, aclarubicin, QT prolonging agents - QT prolonging agents]
[P01BA01, chloroquine, QT prolonging agents - QT prolonging agents]
[N05AA01, chlorpromazine, QT prolonging agents - QT prolonging agents]
[N05AF03, chlorprothixene, QT prolonging agents - QT prolonging agents]
[S03AA07, ciprofloxacin, QT prolonging agents - QT prolonging agents]
[N06AB04, citalopram, QT prolonging agents - QT prolonging agents]
[L01EB10, mobocertinib, QT prolonging agents - QT prolonging agents]
[A04AA01, ondansetron, QT prolonging agents - QT prolonging agents]
[S02DA02, cocaine, QT prolonging agents - QT prolonging agents]
[C01BA13, hydroquinidine, QT prolonging agents - QT prolonging agents]
[P01CB01, meglumine antimoniate, QT prolonging agents - QT prolonging agents]
[L01XA03, oxaliplatin, QT prolonging agents - QT prolonging agents]
[A03FA02, cisapride, QT prolonging agents - QT prolonging agents]
[C01BA03, disopyramide, QT prolonging agents - QT prolonging agents]
[A03FA03, domperidone, QT prolonging agents - QT prolonging agents]
[N01AB08, sevoflurane, QT prolonging agents - QT prolonging agents]
[N05AD08, droperidol, QT prolonging agents - QT prolonging agents]
[N05AL02, sultopride, QT prolonging agents - QT prolonging agents]
[G04BD05, terodiline, QT prolonging agents - QT prolonging agents]
[S01AA17, erythromycin, QT prolonging agents - QT prolonging agents]
[C01BD05, ibutilide, QT prolonging agents - QT prolonging agents]
[N05AE03, sertindole, QT prolonging agents - QT prolonging agents]
[R06AX11, astemizole, QT prolonging agents - QT prolonging agents]
[R06AX12, terfenadine, QT prolonging agents - QT prolonging agents]
[C01BC04, flecainide, QT prolonging agents - QT prolonging agents]
[J02AC01, fluconazole, QT prolonging agents - QT prolonging agents]
[C01BD04, dofetilide, QT prolonging agents - QT prolonging agents]
[P01BX01, halofantrine, QT prolonging agents - QT prolonging agents]
[N05AD01, haloperidol, QT prolonging agents - QT prolonging agents]
[P01BA02, hydroxychloroquine, QT prolonging agents - QT prolonging agents]
[H01BA04, terlipressin, QT prolonging agents - QT prolonging agents]
[L01XX35, anagrelide, QT prolonging agents - QT prolonging agents]
[N05AC03, mesoridazine, QT prolonging agents - QT prolonging agents]
[N07BC02, methadone, QT prolonging agents - QT prolonging agents]
[N05AA02, methotrimeprazine, QT prolonging agents - QT prolonging agents]
[C01BD01, amiodarone, QT prolonging agents - QT prolonging agents]
[S01AE05, levofloxacin, QT prolonging agents - QT prolonging agents]
[N05AG02, pimozide, QT prolonging agents - QT prolonging agents]
[J01MA11, grepafloxacin, QT prolonging agents - QT prolonging agents]
[C10AX02, probucol, QT prolonging agents - QT prolonging agents]
[C01BA02, procainamide, QT prolonging agents - QT prolonging agents]
[N01AX10, propofol, QT prolonging agents - QT prolonging agents]
[J01FA06, roxithromycin, QT prolonging agents - QT prolonging agents]
[C07AA07, sotalol, QT prolonging agents - QT prolonging agents]
